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ABSTRACT 
 
Brian Douglas Beck 
 
Functional Analysis of Two Novel DNA Repair Factors, Metnase and Pso4 
 
Metnase is a novel bifunctional protein that contains a SET domain and a transposase 
domain. Metnase contains sequence-specific DNA binding activity and sequence 
non-specific DNA cleavage activity, as well as enhances genomic integration of 
exogenous DNA. Although Metnase can bind specifically to DNA sequences containing 
a core Terminal Inverted Repeat sequence, this does not explain how the protein could 
function at sites of DNA damage. Through immunoprecipitation and gel shift assays, I 
have identified the Pso4 protein as a binding partner of Metnase both in vitro and in vivo. 
Pso4 is essential for cell survival in yeast, and cells containing a mutation in Pso4 show 
increased sensitivity to DNA cross-linking agents. In addition, the protein has 
sequence-independent DNA binding activity, favoring double-stranded DNA over 
single-stranded DNA. I demonstrated that the two proteins form a 1:1 stochiometric 
complex, and once formed, Metnase can localize to DNA damage foci as shown by 
knockdown of Pso4 protein using in vivo immunofluorescence. In conclusion, this shows 
that Metnase plays an indispensable role in DNA end joining, possibly through its 
cleavage activity and association with DNA Ligase IV. 
 
        Suk-Hee Lee, PhD, Chair 
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SPECIFIC AIMS 
 
In mammalian cells, DNA double-strand breaks induced by IR and V(D)J recombination 
are mainly repaired by nonhomologous end-joining (NHEJ) (1-5). The NHEJ repair 
proteins Ku70/80, DNA PKcs, Artemis, and Xrcc4/ligase IV function both in NHEJ repair 
and V(D)J recombination repair pathways (2, 3, 5-9). Although these proteins seem 
sufficient for end joining in vitro, recent studies suggest the requirement of additional 
unknown factors for end joining in vivo (2, 6, 10-12). Our lab recently showed that a SET 
and transposase domain protein, termed Metnase (also known as SETMAR), increases 
NHEJ repair and mediates genomic integration of exogenous DNA in human 293 cells (13, 
14). Metnase possesses two biochemical activities: histone methylation activity at histone 
3 lysine 4 and lysine 36 (13) associated with chromatin opening (15-17), and unique DNA 
cleavage activity (18-20). Our studies identified two Metnase binding partners, DNA 
ligase IV and hPso4, a human homolog of the PS04/PRP19 gene that functions in DNA 
recombination and error-prone repair (21, 22). Based on these findings, I hypothesize that 
Metnase is required for efficient NHEJ repair in primates. Therefore, the results will likely 
shed new light on mechanisms of the DSB repair pathway and may lead to new therapeutic 
possibilities. This study was designed to identify the mechanism by which Metnase and its 
binding partner(s) improve NHEJ repair. This mechanism was defined by asking four aims 
as follows: 
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Aim 1. In vivo and in vitro analysis of Metnase (SETMAR) Involvement in NHEJ 
repair:  I used both an in vitro end joining assay coupled to E. coli colony formation as 
well as a gel-based inter- and/or intra-molecular end joining assay to examine how 
Metnase influences joining of compatible and non-compatible ends in vitro.  
 
Aim 2. Influence of Metnase DNA cleavage activity on joining of compatible vs. 
non-compatible ends:  Using an in vitro end joining assay I examined how Metnase 
influences DNA end processing. Cell extracts over-expressing Metnase not only 
stimulated DNA end joining but also showed an enhanced end processing of 
non-compatible ends, while the extracts lacking Metnase showed an opposite result. 
Importantly, wt-Metnase and not the D483A mutant lacking DNA cleavage activity 
restores DNA end joining activity in vivo and in vitro, supporting a role for Metnase DNA 
cleavage activity in promoting the processing of non-compatible ends, a prerequisite step 
for the joining of non-compatible ends. 
 
Aim 3. hPso4 is a Metnase binding partners that mediate Metnase function(s) in NHEJ 
repair:  I showed that hPso4 is a Metnase binding partner that forms a stable complex with 
Metnase on both TIR and non-TIR DNA. The transposase domain essential for Metnase-TIR 
interaction is not sufficient for its interaction with non-TIR DNA in the presence of hPso4. I 
also showed that hPso4 is induced in vivo following IR treatment and co-localized with 
Metnase at DSB sites. Cells treated with hPso4-siRNA failed to show Metnase’s localization at 
DSB sites and Metnase-mediated stimulation of DNA end joining coupled to genomic 
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integration, suggesting that hPso4 is necessary to bring Metnase to the DSB sites for its 
function(s) in DNA repair.  
 
Aim 4. In vitro analysis of Metnase and/or hPso4 binding to dsDNA:  I showed that 
Metnase exists as a dimer, and forms a 1:1 stoichiometric complex with hPso4 tetramer on 
dsDNA. Further analysis revealed that hPso4 is solely responsible for binding to DNA 
once the two proteins form a stable complex, although both Metnase and hPso4 can 
independently interact with TIR. I also found that Metnase undergoes a conformational 
change upon binding to DNA, and Metnase bound to TIR is significantly less effective in 
interacting with hPso4 than free Metnase, suggesting that hPso4, once forming a complex 
with free Metnase, negatively regulates TIR binding activity of Metnase (transposase), 
which perhaps is necessary for Metnase localization at non-TIR sites such as DSBs. 
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BACKGROUND AND SIGNIFICANCE 
 
B.1. End joining of DNA double strand breaks (DSBs) in higher eukaryotes  
DSB repair can occur through either NHEJ or homologous recombination (HR), while 
single-strand annealing is shared between HR and NHEJ (2, 3, 23-25). The error-free 
pathway of HR restores broken DNA to its original sequence (26-29), whereas the 
error-prone pathway of NHEJ often processes the DNA by adding or deleting nucleotides 
before joining the ends (4, 30). However, because HR requires a template chromosome, it 
is limited to S/G2 phase in most eukaryotes (29), while NHEJ has no such cell cycle 
limitations (31). Although many of the proteins involved in the two major DSB repair 
pathways have been identified, the precise mechanisms involved remain poorly 
understood.  
 
i) NHEJ pathway:  
NHEJ repair involves a direct rejoining of the separated DNA ends without the need for a 
homologous template (32, 33). The repair of DSBs by NHEJ requires the coordinated 
assembly of damage-responsive proteins at the damage site (2, 3). Upon DSB damage, 
Ku70/80 complex first binds to the DNA ends (4, 34-38) and recruits DNA-dependent 
protein kinase catalytic subunit (DNA-PKcs) (39-41), a 465-kDa Serine/Threonine kinase 
in the phosphoinositol 3-kinase (PI3K) superfamily that mediates bridging of the free ends 
and then undergoes activation of its kinase (23, 42-44). Kinase activity, particularly 
phosphorylation at T2609 and S2056 is required for NHEJ (45), but currently its function 
remains unclear. Artemis associates with DNA-PKcs at the DSB and functions to process 
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the ends, potentially enhancing homology for re-ligation through a ssDNA-specific 5’3’ 
exonuclease (46, 47). Similarly, Mre11 of the MRN complex processes ends through 
3’5’ exonuclease activity (46, 48), as does WRN, a RecQ-like helicase that is 
phosphorylated by DNA-PKcs and stimulated by Ku complex (49-52). Following 
exonuclease activity at the free ends, DNA polymerases such as Pol λ and Pol µ are 
believed to function in filling in of any remaining overhang (53-56). After 
auto-phosphorylation, DNA-PKcs mediates recruitment of the XRCC4-DNA Ligase IV 
complex to the DBS site (57-59). The recruitment of the XRCC4-DNA ligase IV complex 
is essential for the final step of ligation (5, 38, 60, 61). XLF, also known as Cernunnos, is a 
newly identified core factor of the NHEJ pathway (62-64), and is known to stimulate DNA 
ligase IV in vitro through its interaction with XRCC4 (62, 64, 65).  
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Figure 1. Model of NHEJ in mammalian cells. Non-Homologous End Joining (NHEJ) is 
the major pathway for DNA repair in mammals due to its cell cycle independence. Briefly, 
Ku70/80 binds the broken ends and DNA-PKcs moves to the site of damage and is 
autophosphorylated. After end processing, XRCC4, DNA Ligase IV, and XLF are    
recruited to the repair complex, and ligation occurs. 
 
 
ii) Homologous recombination repair (HRR) pathway:  
HR-mediated DSB repair is highly conserved through evolution and comprise the primary 
DSB repair pathway in prokaryotes and lower eukaryotes (24). In the earliest stages of 
DSB repair by HRR, ataxia-telangiectasia mutated protein (ATM) senses and perhaps 
binds to the DSB (66-68), and phosphorylates histone H2AX (69, 70), which would then 
attract breast cancer susceptibility gene 1 (BRCA1) (66, 67) and Nijmegen breakage 
syndrome protein 1 (Nbs1) (66, 71-73), also phosphorylated by ATM (24). BRCA1 may 
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help serve as an anchor and coordinator of the repair events that follow (24, 74). BRCA2, 
attracted to the DSB by BRCA1, facilitates the loading of RAD51 onto RPA-coated DNA 
overhangs with the help of RAD51 paralogs that in turn attract RAD52 and RAD54 (75, 
76), perhaps with the help of DNA helicase(s), the Bloom syndrome protein (BLM) and/or 
Werner syndrome protein (WRN) (77, 78). BLM and WRN interact with Holliday 
junctions (79, 80). From this point, there are two possibilities to finish HRR; 1) by 
non-crossing-over in which case the Holliday junctions disengage and DNA strands pair 
followed by gap filling (81), or 2) by a crossing-over from Holliday junction resolution and 
gap-filling (82). It is not known as to which DNA polymerase and ligase are involved in the 
polymerization and ligation steps. 
 
B.2. Other factors linked to NHEJ repair 
i) Metnase:  
Metnase, also known as SETMAR, is a 80-kD novel SET [Su(var)3-9, Enhancer-of-zeste, 
Trithorax]- transposase fusion protein found in anthropoids (83, 84). It possesses histone 
lysine methyltransferase (HLMT) activity at histone 3 lysine 4 and lysine 36 (13) 
associated with chromatin opening (15, 17, 85-87) and a transposase domain containing 
the DDE acidic motif conserved among retroviral integrase and transposase families 
(Figure 2). It also possesses a sequence-specific DNA binding activity that recognizes a 
19-mer core of the 5’-terminal inverted repeats (TIR) of the Hsmar1 element (18, 20, 83). 
The human chromosomes contain over 7000 sites that are either identical or with a single 
mismatch to the 19 bp of Metnase binding site (18, 20, 83, 88), suggesting that the human 
genome contains an enormous reservoir of potential Metnase binding sites. However, 
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unlike transposases, Metnase does not have any TIR sequences flanking its genetic 
material, indicating that it is not encoded by a human transposon (13, 84, 89). The Metnase 
SET domain contains homologies to the two conserved amino-acid sequences in the SET 
domain of SUV39H1 (NHSCXPN and GEELXXXY) that are likely responsible for the 
histone methyltransferase activity (90) (Figure 1). Similar to SUV39H1, Metnase also has 
a perfect consensus post-SET domain (CXCX4C). 
 
The discovery of a potential role for Metnase in DNA repain resulted from the finding 
that Metnase over-expression increased precise and imprecise NHEJ repair in vivo (13). 
Specifically, over-expression of Metnase resulted in approximately a 3-fold increase in 
both precise and imprecise NHEJ as measured by colony formation following treatment 
with IR, while knockdown of Metnase expression through Metnase-specific siRNA 
resulted in a 12-20 fold reduction in NHEJ repair as analyzed by the same methods, 
providing further evidence of a linkage between Metnase and NHEJ (13, 91). The 
promotion of DSB repair by the SET domain of Metnase suggests that Metnase may 
function in opening chromatin, as well as enhancing accessibility of repair factors. In 
support of this hypothesis, mutating essential amino acid residues in the histone 
methyltransferase domain of Metnase reduced the ability to stimulate NHEJ repair (13). 
 
Metnase is also involved in genomic integration of foreign DNA (13, 14), and this may 
also rely on other NHEJ proteins (92-94). Metnase over-expression in human 293 cells 
increased integration of a Metnase expression vector, and it increased integration of a 
co-transfected vector (13), suggesting that Metnase promotes genomic integration both 
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in cis and in trans. Upon deletion of either the SET or the transposase domain, the ability 
of the other Metnase domain to promote foreign DNA integration was abrogated, 
indicating that both domains are required for this function (13). Over-expression of 
Metnase also promoted integration of retroviral DNA (13, 14). Metnase promotion of the 
integration of widely varied exogenous DNA sequences integration indicates that this 
activity is DNA sequence-independent. This distinguishes Metnase from transposases, 
which act only on transposon-specific sequences.  
 
 
Figure 2. Schematic diagram of Metnase. The PreSET domain contains a cysteine- and 
histidine-rich putative Zn2+  binding motif. The SET domain has the histone lysine methyl 
transferase motif, and the transposase domain contains helix-turn-helix and DDE-like 
motifs.  
 
 
ii) hPso4:  
hPso4 is a human homolog of the 55-kDa protein encoded by the PS04/PRP19 gene in 
Saccharomyces cerevisiae that has pleiotropic functions in DNA recombination and 
error-prone repair (21). hPso4 contains six successive WD-40 motif at the C-terminus that 
is known to form a structural interface for the assembly of multiprotein complexes (22, 95), 
and has been identified as a component of the nuclear matrix (NMP200) (96) (Figure 3). 
hPso4 is a part of the pre-mRNA splicing complex consisting of Pso4, Cdc5L, Plrg1, and 
Spf27 (97), and has been previously linked to DNA repair through a direct physical 
 10 
interaction between Cdc5L and WRN, the protein deficient in Werner Syndrome 
(98). Additionally, Pso4 mutants in S. cerevisiae show heightened sensitivity to interstrand 
crosslink DNA damage (21). Recent studies with hPso4 indicated that it interacts with 
terminal deoxynucleotidyl transferase (TdT). TdTucleotides to DNA ends generated 
during V(D)J recombination that are subsequently processed by proteins involved in 
general DSB repair pathways (2, 22, 45). Purified hPso4 binds double-stranded DNA in a 
sequence-nonspecific manner but does not bind single-stranded DNA. hPso4 expression is 
induced in cells by IR and interstrand crosslinking (22). Loss of hPso4 expression by 
siRNA results in accumulation of DSBs and decreased cell survival after DNA damage. 
Taken together these data suggest that hPso4 plays a unique role in mammalian DNA DSB 
repair. Nonetheless, the specific role(s) for hPso4 in DSB repair is not known. 
 
 
 
Figure 3. Schematic diagram of hPso4. The U-box domain is involved in ubiquitin ligase 
activity. The six WD-40 motifs at the C-terminus of the protein act as a site for 
protein-protein interactions, and possibly as a scaffolding for assembly of protein 
complexes. 
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MATERIALS AND METHODS 
 
Cells, Enzymes, and Chemicals  
The Human Embryonic Kidney (HEK 293) cell line was grown in Dulbecco’s modified 
Eagle’s media (DMEM)-F12 (GIBCO-BRL) supplemented with 10% fetal calf serum 
(GIBCO-BRL), penicillin (10 units/mL, Sigma), and streptomycin (0.1 mg/mL, Sigma). 
Mouse Ku80-/-, DNA-PK-/- and ATM-/- cells were previously described (13, 99). 
Restriction enzymes (BamH I, Hind III, Kpn I, EcoR V, and Pst I) were obtained from 
Promega (Madison, WI). [γ-32P]-ATP (3000 Ci/mmol) was from Perkin-Elmer and 
Analytical Science (Boston, MA) and Bradford reagents and protein molecular weight 
markers were purchased from Bio-Rad (Hercules, CA). The oligonucleotides were 
obtained from Integrated DNA Technologies (Coralville, IA). 
Cis-dichlorodiammineplatinum(II) (CDDP; cisplatin) and anti-FLAG and -V5 monoclonal 
antibodies were obtained from Sigma (St. Louis, MO) and Invitrogen (Carlsbad, CA) 
respectively. DE81 filters from Whatman Bio System (Maidstone, England), 
heparin-Sepharose from Amersham Biosciences (Piscataway, NJ), and Bradford reagents 
and protein molecular weight markers were purchased from Bio-Rad (Hercules, CA). An 
anti-Metnase antiserum (polyclonal) was generated from rabbits using two peptides 
representing amino acids 483-495 (DEKWILYDNRRRS) and 659-671 
(WQKCVDCNGSYFD) (13), and an anti-Pso4 polyclonal antibody specific for human 
Pso4 was obtained from Calbiochem (Gibbstown, NJ). Flag peptide was synthesized from 
the peptide core facilities at the IU School of Medicine.  
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Generation of stable cell lines, preparation of cell extracts, and immunoblot analysis 
HEK293 cells stably over-expressing wt-Metnase or wt-hPso4 were generated by 
transfection with a vector harboring FLAG-Metnase, V5-Metnase, or FLAG-hPso4 using 
FuGENE6 transfection reagent (Roche Molecular Biologicals, Basel, Switzerland). This 
was followed by selection in G418 (Invitrogen) supplemented media for 14 days, after 
which a single colony was isolated and amplified. For preparation of cell extracts, cells 
were briefly washed with phosphate-buffered saline (PBS) and lysed in a buffer containing 
25 mM HEPES (pH 7.5), 0.3 M NaCl, 1.5 mM MgCl2, 0.2 mM EDTA, 0.5% Triton X-100, 
20 mM β-glycerolphosphate, 1 mM sodium vanadate, 1 mM DTT, and protease inhibitor 
cocktails (Sigma). Cell lysates (50 µg) were loaded onto a 10% SDS-PAGE and following 
gel electrophoresis, proteins were transferred to a PVDF membrane (Millipore, Billerica, 
MA), immunoblotted with primary antibody followed by peroxidase-coupled secondary 
antibody (Amersham, Piscataway, NJ) and an enhanced chemi-luminescence (Amersham, 
Piscataway, NJ) reaction prior to visualization on Kodak-o-mat film (Eastman Kodakm 
Rochester, NY). Metnase under-expressors were generated by stable transfection of the 
human 293 cell line by Oligofectamine with either pRNA-U6.1/Hyg (Genescript) for the 
control or pRNA-U6.1/Hyg-siRNA-Metnase to reduce the expression of endogenous 
Metnase. Transfectants were selected in hygromycin (150 µg/mL) for 10-14 days. Reverse 
transcription-PCR was used to initially screen for clones that had a reduced expression of 
Metnase compared to the control U6 clone. The primers for Metnase and 18S and the 
sequence for the Metnase siRNA were described previously (13). 
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Purification of FLAG-Metnase and FLAG-hPso4  
Metnase- (or hPso4-) expressing cells (1.6 x 108) were suspended in 20 mL of extraction 
buffer (TEGDN; 50 mM Tris-HCl pH 7.5, 1 mM EDTA, 10% glycerol, 5 mM DTT, 1.0% 
Nonidet-P40, and mammalian protease inhibitor cocktails containing 0.2 M NaCl), and 
centrifuged (40,000 x g) for 3 hours. The supernate was incubated at 4˚C for 60 min with 
anti-FLAG mouse monoclonal antibody (Sigma) that had been pre-equilibrated with 
TEGDN extraction buffer containing 0.2 M NaCl. The antibody-protein solution was then 
loaded onto a column containing protein G agarose (2.5 mL). The column was washed with 
three column volumes of TEGDN-1.5 M NaCl buffer prior to elution of the protein with 
TEGDN-0.2 M NaCl containing FLAG peptide (500 µg/mL). The elutant was checked for 
protein concentration using an Ultrospec 2000 spectrophotometer (Pharmacia, Stockholm, 
Sweeden) and positive fractions were combined and dialyzed against 50 mM Tris-Cl pH 
7.5, 50 mM NaCl, 100 µM DTT, 0.01% NP-40, and 10% glycerol at 4°C overnight and 
stored at -80°C.  
 
SDS-PAGE and western blot analysis 
Protein fractions were analyzed by 10% SDS-polyacrylamide gel electrophoresis 
(SDS-PAGE). For visualization, the gel was silver-stained by fixation overnight in 50% 
methanol, 12% acetic acid, and 500 µL/L 37% formaldehyde. The gel was dehydrated in 
50% ethanol for 20 minutes, then briefly rinsed with sodium thiosulfate (0.2 g/L) for 1 
minute to remove any trace silver complexes in the gel. The gel was rinsed three times for 
1 minute each, then stained with silver nitrate (0.2 g/L) and 37% formaldehyde (750 µL/L). 
After three additional rinses in deionized water, the gel was developed using sodium 
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carbonate (6 g/L), sodium thiosulfate (0.2 g/L), and 37% formaldehyde (500 µL/L). 
Staining was stopped with 1% acetic acid. For western blotting, protein was then 
transferred to polyvinylidene difluoride (PVDF) membrane, probed with an anti-FLAG 
(monoclonal mouse IgG, Sigma) or an anti-Metnase antibody (polyclonal rabbit IgG) 
followed by horseradish peroxidase-conjugated secondary antibody. Proteins were 
visualized using the ECL system (Amersham Biosciences). 
 
Electrophoretic mobility shift assay (EMSA) of protein-DNA interaction 
Duplex DNA was labeled with [gamma-32P]-ATP (3,000 Ci/mmol) and T4 polynucleotide 
kinase (Roche Molecular Biologicals) according to the manufacturer’s instructions. The 
indicated amount of purified Metnase and/or hPso4 was incubated in a reaction mixture 
containing 50 mM Tris-Cl pH 7.5, 50 mM NaCl, 1 mM DTT, 0.2 mg/mL BSA, and 5% 
glycerol for 15 minutes at room temperature. Next, 200 fmol of 5’-32P-labeled DNA was 
added and the reaction incubated at room temperature for 15 min. The Metnase-DNA 
complex was analyzed on either 5% polyacrylamide gel (acrylamide:bis-acrylamide = 
29:1) in 0.5X TBE or 1% vertical agarose gel in 1X TBE. The gels were dried and exposed 
to x-ray films (Kodak). For quantification, the bands of interest were excised from the gels 
and measured for radioactivity using a Beckman Scintillation Counter LS 6500. 
Alternatively, the individual DNA was quantified using the NIH image program (version 
1.62).  
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DNA substrates 
DNA substrates were obtained from the Integrated DNA Technologies (Coralville, IA). 
The 32-nucleotide dsDNAs containing either the 19-mer core sequence necessary for 
Metnase binding (TIR32) or 2x5 nucleotide mutation at the core (MAR3M) were 
previously described. For Metnase-induced DNA looping experiments, 118 base DNA 
oligonucleotides containing either two TIR32 sequences in the forward direction seperated 
by 54bp of random nucleotides (Fwd-Fwd template: 5'-AGG TTG GTG CAA AAG TAA 
TTG CGG AGC TGG CTA TCG GAA CTC TCG GAA GTT GGG TCA GTT ACA ACG 
CGC CAC CCG CGC CCC GTA CTG ATA GCA GGG TGC AAA AGT AAT TGC 
GGA GGT T-3') or a forward TIR32 sequence and a reverse TIR32 sequence separated by 
the same 54-bp nucleotides (Fwd-Rev template: 5'-AGG TTG GTG CAA AAG TAA TTG 
CGG AGC TGG CTA TCG GAA CTC TCG GAA GTT GGG TCA GTT ACA ACG CGC 
CAC CCG CGC CCC GTA CTG ATA GCA GGG CGT TAA TGA AAA CGT GGA 
GGT T-3') were annealed. For Metnase-induced DNA looping experiments, 118 base 
DNA oligomers containing either two TIR32 sequences in the forward direction seperated 
by 54 bp of random nucleotides (Fwd-Fwd template: 5'-AGG TTG GTG CAA AAG TAA 
TTG CGG AGC TGG CTA TCG GAA CTC TCG GAA GTT GGG TCA GTT ACA ACG 
CGC CAC CCG CGC CCC GTA CTG ATA GCA GGG TGC AAA AGT AAT TGC 
GGA GGT T-3') or a forward TIR32 sequence and a reverse TIR32 sequence separated by 
the same 54-bp nucleotides (Fwd-Rev template: 5'-AGG TTG GTG CAA AAG TAA TTG 
CGG AGC TGG CTA TCG GAA CTC TCG GAA GTT GGG TCA GTT ACA ACG CGC 
CAC CCG CGC CCC GTA CTG ATA GCA GGG CGT TAA TGA AAA CGT GGA 
GGT T-3') were annealed. 
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Identification of Metnase-associated proteins 
Proteins associated with Metnase were collected by immunoprecipitation with an anti-Flag 
M2 antibody (Sigma) and Protein G agarose beads (Upstate, Temecula, CA). Whole cell 
extracts of 107 293 cells over-expressing Flag-Metnase were incubated with 3 µg antibody 
at 4°C for 2 hrs, followed by addition of 100 µL Protein G agarose beads overnight. The 
complex was washed four times with 25 mM Tris-HCl (pH 7.5) containing 250 mM NaCl 
prior to running on a 10% SDS-PAGE. After staining the gel with Coomassie blue, 
individual bands were excised and immersed in 100 µL of 0.1 M ammonium bicarbonate 
and 50% acetonitrile (by volume) to completely cover the gel pieces. After incubation at 
37°C for 30 min, the gel pieces were dehydrated with 100 µL of acetonitrile for 5 min and 
rehydrated with 100 µL of 10 mM DTT at 55°C for 45 min for reduction. Following 
alkylation with 100 µL of 55 mM iodoacetamide for 30 min at 37°C, the gel pieces were 
briefly dehydrated with 100 µL of acetonitrile and treated with a trypsin solution (Promega 
V5280, 0.1-0.5 µg) overnight at 37°C. Following trypsin digestion, peptides were 
extracted with 0.1% trifluoroacetic acid and injected onto a 75 µm x 5 cm C-18 
reverse-phase column. Peptides were eluted with a gradient from 5-45% acetonitrile over 
30 min using an Agilent 1100 series nanopump. The reverse phase column was interfaced 
with a LTQ ion trap mass spectrometer (Thermo, Waltham, MA), and data were collected 
in the Data Dependent Neutral Loss MS3 mode. MS/MS spectra were searched against the 
International Protein Index (IPI) human protein database using a SEQUEST algorithm. 
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Transfection of cells with siRNA 
A control scrambled siRNA, Metnase-specific, and hPso4-specific siRNA were obtained from 
Dharmacon Research Co. (Lafayette, CO). Human 293 cells (2.0 × 104) were plated on 6-well 
plates and incubated for 24 hrs prior to transfection. Cells were washed once with fresh 
medium and siRNA (0.2-0.4 µM) was diluted in DMEM/F12 to a final volume of 200 µL. The 
diluted siRNA samples were combined with Oligofectamine (Invitrogen), and incubated for 20 
min at room temperature before adding to cells. After incubation for 4 h, 0.5 mL culture 
medium containing 30% serum was added without removing the transfection mixture, and 
cells were further incubated for 48-72 hrs. Cell lysates were prepared and examined for 
efficacy of siRNA by western blot analysis.  
 
Laser scanning confocal microscopy 
Cells were grown to 70% confluence on a sterilized Labtek II coverslip, irradiated with 
Gammacell-40 exactor (Nordion, Ottawa, Canada) as a 137Cs source, and further incubated at 
37°C until harvest. Immunofluorescence microscopy was carried out as described previously 
(99, 100). Images were collected using a Zeiss LSM-510 confocal microscopy.  
 
DNA end joining coupled to genomic integration analysis 
Chromosomal integration was analyzed by the ability of cells to pass on to progeny foreign 
non-homologous DNA containing a selectable marker. pRNA/U6.Hygro plasmid was 
transfected into 293 cells stably expressing mock (pFlag2 vector), pFlag2-wtMetnase, or 
pFlag2-D483A using calcium phosphate transfection method as previously described (101). 
Forty-eight hours after transfection, varying numbers of cells were plated into 100 mm dishes 
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and 24 hours later the selection media (hygromycin: 0.15 mg/mL) was added. Cells were 
incubated for 14 days in the presence of hygromycin. Harvested cells were washed twice with 
PBS, stained with 0.17% methylene blue in methanol, and colonies defined as greater than 50 
cells were counted. All experiments were performed three times in triplicate.   
 
Glycerol gradient sedimentation 
Immunoaffinity-purified Metnase or hPso4 proteins were sedimented through a linear 10-35% 
(vol/vol) glycerol gradient at 45,500 rpm for 26 hrs at 4°C. Fractions (175 µL/each) were 
collected from the bottom, and the aliquots were run on 10% SDS-PAGE for silver staining 
and western blot analysis or 5% native gel for dsDNA binding activity.  
 
Preparation of cell extracts 
Whole cell extracts were prepared from the human 293 cell line as described previously 
(102). Briefly, human 293 cells expressing different levels of Metnase were grown in 150 
mm dishes. Cells were harvested at ~90% confluency, washed three times in ice-cold PBS 
and once in hypotonic lysis buffer (10 mM Tris-HCl, pH 8.0, 1 mM EDTA, and 5 mM 
DTT). Cells were resuspended in 500 µL of hypotonic buffer, incubated on ice for 20 min 
and homogenized after addition of protease inhibitors (0.17 µg/mL phenylmethyl-sulfonyl 
fluoride, 1 µg/mL aprotinin, 0.01 units/mL trypsin inhibitor, 1 µg/mL pepstatin, 1 µg/mL 
chymostatin, 1 µg/mL leupeptin). Following 20 min incubation on ice, 0.5 volume of 
high-salt buffer (50 mM Tris-HCl, pH 7.5, 1 M KCl, 2 mM EDTA, 2 mM DTT) was added 
to the cell lysates prior to centrifugation for 3 hr at 42,000 rpm in a Beckman SW55 rotor. 
The supernates were dialyzed against E buffer (20 mM Tris-HCl pH 8.0, 0.1 M KOAc, 
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20% glycerol (v/v), 0.5 mM EDTA, 1 mM DTT) for 3 hours, flash-frozen on dry ice, and 
stored at -80°C. 
 
In vitro DNA end joining assay coupled to E. coli colony formation  
Reactions mixtures (100 µL) contained 50 mM Tris-HCl (pH 7.5), 0.5 mM Mg-acetate, 60 mM 
potassium acetate, 2 mM ATP, 1 mM DTT, and 100 µg/mL BSA. Where indicated, dNTPs 
(2.5 mM) were included in the reaction mixtures. Cell-free extracts were pre-incubated for 5 
min at 37°C before addition of 1.0 µg of DNA substrate. Following incubation for 1 hour at 
37°C, DNA products were deproteinized, purified by QIAQuick Kit (Qiagen, Valencia, CA), 
and transformed into high efficiency E. coli DH5-alpha competent cells (> 1.0 x 108 cfu/µg) 
for colony formation. Where indicated, PCR amplification of end joining products was 
performed using Taq DNA polymerase (Promega, Madison, WI) and two primers (M13 
Reverse and T7 primers). 
 
A gel-based DNA end joining assay in vitro (Baumann and West end joining assay)(102) 
Different volumes of reaction mixtures containing 60 µg of whole cell extracts (human 293 
cells) and 5’-32P-pBS DNA (20 ng) were linearized with Kpn I were incubated for 2 hr at 37°C, 
and DNA products were deproteinized and analyzed by 0.8% vertical agarose gel 
electrophoresis. Individual end joining products (circular- monomer, dimer, and trimer) were 
identified by T4 ligase-treated marker DNA.  
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DNA cleavage assay 
For a cleavage assay of supercoiled DNA, reaction mixtures contained 25 mM Tris-HCl (pH 
7.5), supercoiled pBluescript II SK+ phagemid DNA (pBS; 100 ng), the indicated amounts of 
either MgCl2 (or MnCl2), 10 mM DTT, and indicated amount of Metnase. The mixtures were 
incubated at 37°C for 60 min. After incubation, the mixtures were subjected to 1% agarose gel 
electrophoresis in TBE (Tris-Boric acid-EDTA) buffer following addition of 5 µL of sample 
loading buffer consisting of 5% sarkosyl, 0.0025% bromophenol blue and 25% glycerol. DNA 
separated on agarose gel were stained with ethidium bromide, visualized on a UV 
transilluminator, and analyzed with the NIH image system (version 1.62). For DNA cleavage 
assay using oligonucleotides, reaction mixtures (20 µL) containing 5’-32P-dsDNA (200 fmol) 
were incubated with indicated amounts of Metnase in the presence of 1 mM MgCl2. After 
incubation at 37°C for 60 min, reaction mixtures were analyzed by 16% denaturing 
polyacrylamide gel for DNA cleavage.  
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STUDIES 
 
AIM 1. IN VIVO AND IN VITRO ANALYSIS OF METNASE (SETMAR) 
INVOLVEMENT IN NHEJ REPAIR   
 
1.1. Metnase’s involvement in NHEJ repair (I): From an in vitro end joining assay 
coupled to E. coli colony formation 
A recent in vitro end joining assay developed by Budman and Chu (103, 104) is an 
intermolecular end joining reaction that was based on qPCR amplification of joined DNA 
molecules in the presence of cell-free extracts. The end joining assay is dependent on the 
Ku complex and DNA-PKcs, and is sensitive to wortmannin. Most importantly, it provides 
a unique tool to measure joining of various compatible and non-compatible ends, which is 
crucial for understanding of how DNA ends are processed. On the other hand, this method 
measures end joined products by PCR amplification. Only one of 10 possible end joining 
products is detected, and it does not reflect all end joining activity occurred in the reactions 
(103). Intermolecular joining of two selective ends may be affected by relative activity of 
the nine other possible end joining events in the reaction mixtures.  
 
To evaluate DNA end joining activity quantitatively, I modified an in vitro end joining 
assay originally described by Baumann and West (102). Circular duplex DNA was 
linearlized by restriction endonuclease digestion, then incubated in the presence of 
dialyzed cell free extract. DNA was isolated from the reaction and transformed into E. coli. 
End-joining was quantified by formation of ampicillin-resistant E. coli colonies. (Figure 
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4A). In this way, not only are all possible end joining products counted, but also identify 
essential factors for re-ligation. In addition, those factors that may not be crucial for end 
joining yet affect efficacy or kinetics of DNA end-joining can be determined.  
 
Ampicillin-resistant E. coli colonies were proportionally increased with the amount of 
linearized DNA and the cell extracts, and reached a maximum in the presence of 30 µg cell 
extracts (data not shown). I then tested whether our in vitro end joining assay coupled to E. 
coli colony formation represents NHEJ repair rather than a simple end joining. Since NHEJ 
repair is dependent on the presence of DNA-PK, I examined the effect of wortmannin, a 
specific PI-3 kinase family inhibitor. Colony formation was dependent on ATP and Mg+2, 
but was completely inhibited in the presence of wortmannin (Figure 4B). Importantly, 
joining of compatible ends with 5’- and 3’-overhangs, or blunt ends showed similar levels 
of re-ligation, and were supported by cell extracts prepared from wild-type mouse 
fibroblast and ATM-/- cells, but not DNA-PKcs-/- or Ku80-/- cells (Figure 4C). This result 
was in keeping with previous in vitro end joining coupled to PCR assays, and suggests that 
the in vitro end joining assay coupled to E. coli colony formation represents NHEJ repair 
rather than a simple end joining. This provides a useful tool for quantitative measurement 
of intramolecular end joining in vitro. 
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Figure 4. In vitro end joining and E. coli colony formation. A) The assay measured 
intramolecular end joining of linearized plasmid DNA in the presence of cell extracts. 
Following DNA isolation, DNA was transformed into E. coli for colony counts. B) In vitro 
end joining assay is sensitive to wortmannin. In vitro end joining assay was carried out in 
the presence/ absence of 1 mM ATP, 1 mM MgCl2, or 10 uM wortmannin for 60 min prior 
to DNA isolation and E. coli transformation. The figure is representative of three DNA end 
joining assays. Values are averages (±SEM) of 6 independent assays. *P < 0.005; **P = 
0.01. C) In vitro end joining assay is dependent on Ku80 and DNA-PKcs. Mouse fibroblast 
cells lacking Ku80, DNA-PKcs, or ATM were used to prepare cell extracts. The end 
joining assay coupled to E. coli colony formation was carried out in the presence of 
linearized pBS with 5’-overhangs, 3’-overhangs, or blunt ends. Values are averages 
(±SEM) of 3 distinct determinations. P < 0.01; *P = 0.05.  
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1.2. Cell extracts lacking Metnase failed to support the joining of both compatible 
and non-compatible ends 
Metnase promotes NHEJ repair and mediates genomic integration of exogenous DNA in 
human 293 cells. I therefore examined whether Metnase influences DNA end joining in 
vitro. HEK293 cells were transfected with a V5-tagged pcDNA5.1 plasmid containing a 
Metnase cDNA, and then were selected with media supplemented with G418 to isolate 
colonies of cells that stably expressed the plasmid. G418 resistant cells were amplified and 
whole cell extracts collected. HEK293 cells were transiently transfected with Metnase 
siRNA for 48 hours and whole cell extracts collected. Western blot comparing wild-type 
HEK293 cells, with both Metnase under- and over-expressor extracts are seen in Figure 
5A. Compared to control 293 cell extracts, extracts from cells over-expressing Metnase 
showed a 1.25-1.3 fold increase in DNA end joining activity, while those prepared from 
cells transfected with siRNA-Met showed 8-20 fold reduction in the joining of compatible 
ends (Figure 5B). A similar result was obtained when joining activity of various 
non-compatible ends was measured (Figure 5C). This finding is in keeping with our 
previous in vivo finding that Metnase is involved in DNA end joining repair. It also 
validates that the in vitro end joining assay coupled to E. coli colony formation as a 
valuable tool to explore the role(s) for Metnase and other repair factor(s).  
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Figure 5. Colony formation +/- Metnase. Cell extracts lacking Metnase failed to support 
joining of both compatible and non-compatible ends. A) Effect of Metnase-siRNA on Metnase 
expression. Wild-type Human 293 cells (lane 1) were overexpressed with V5-Metnase (lane 2) 
or treated with Metnase-specific siRNA (lane 3). After 48 hrs, cell extracts were analyzed for 
Metnase expression by western blot using an anti-V5 antibody. Expression of Ku70 was 
included as a loading control. B) Cell extracts lacking Metnase failed to support the joining of 
compatible ends in vitro. Cell extracts (30 µg) prepared from 293 cells expressing different 
level of Metnase (293 cells, filled bar; Metnase over-expressor, open bar; Metnase-siRNA, 
striped bar) were incubated for 60 min with linearized pBS DNA (1.0 µg) in the presence of 1 
mM MgCl2 and 1 mM ATP. Following incubation, DNA was isolated and transformed into E. 
coli for colony counts. Numbers 1-3 represent DNA substrates with different ends indicated on 
the right side of the figure. The figure is representative of three DNA end joining assays. 
Values are averages (±SEM) of 3 distinct determinations. P < 0.01; *P = 0.05; **P = 0.08. C) 
Cell extracts lacking Metnase failed to support the joining of non-compatible ends in vitro. 
Experiments were done as in panel B, except for the use of linearized pBS with non-compatible 
ends (1.0 µg). Numbers 1-3 represent DNA substrates with different ends as indicated on the 
right. Values are averages (±SEM) of 5 distinct determinations. P < 0.01; *P = 0.05.   
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1.3. Addition of wt-Metnase and not D483A lacking DNA cleavage activity restored 
end joining activity of cell extracts lacking Metnase   
To see whether poor end joining activity associated with cell extracts prepared from 
siRNA.Metnase-treated cells was due to a lack of Metnase, I carried out an add-back 
experiment. Purified wt-Metnase was added to the cell extracts for restoration of end 
joining activity. Addition of wt-Metnase to cell extracts (prepared from 
siRNA.Metnase-treated cells) effectively restored joining of both compatible and 
non-compatible ends. The Metnase D483A mutant lacking DNA cleavage activity partially 
restored joining of compatible but not non-compatible ends (Figure 6A and 6B). This result 
suggests that Metnase’s DNA cleavage activity may be necessary for joining of 
non-compatible ends, whereas the interaction of Metnase with DNA Ligase IV may be 
necessary for joining of compatible ends (14).  
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Figure 6. Colony formation using D483A mutant Metnase. Addition of wt-Metnase 
and not D483A restored DNA end joining activity with cell extracts lacking Metnase. For 
an in vitro end joining assay, cell extracts were prepared from human 293 cells (control) or 
293 cells treated with siRNA-Met. Where indicated, 0.2 µg of purified mammalian wt-Met 
[siRNA (Met) + wt-Met] or D483A [siRNA(Met) + D483A] was added to the extracts 
prepared from Met.siRNA-treated cells prior to end joining reactions. Reaction mixtures 
(100 µL) containing 30 µg of cell extracts, linearized pBS DNA (1.0 µg), 1 mM MgCl2 and 
1 mM ATP were incubated for 60 min, and DNA was isolated for transformation into E. 
coli for colony counts. Numbers 1-3 represent DNA substrates with different compatible 
ends (panel A) or non-compatible ends (panel B) indicated on the right side of the figure. 
The figure is representative of three DNA end joining assays. Values are averages (±SEM) 
of 3 separate experiments (panel A, P < 0.01, *P = 0.05, **P = 0.08; panel B, P < 0.01, *P 
= 0.05).  
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1.4. Involvement of Metnase in NHEJ repair (II): The Baumann-West’ in vitro end 
joining assay 
To further understand Metnase’s involvement in NHEJ, the modified Baumann-West end 
joining assays were carried out in the presence of cell free extracts and 5’-32P-labeled 
linearized pBS plasmid DNA. Intra-molecular DNA end-joining products 
(monomer-circular) were preferentially formed when DNA and protein concentrations 
were low (30 µL reaction volume), while inter-molecular joining (dimer and trimer) was 
favored by higher DNA and protein concentrations (Figure 7A, lanes 2 vs. 3-5). A faster 
migration of the monomer-circular DNA was likely due to a formation of 
minichromosomes constructed by reconstituting complexes of core histones in the cell 
extracts with the pBS DNA. Formation of end joining products was ATP-dependent and 
wortmannin-sensitive (Figure 7B). In keeping with the intra-molecular end joining assay 
(Figure 5B), the modified Baumann-West end joining assay showed that cell extracts 
under-expressing Metnase, compared to control cell extracts, poorly supported joining of 
compatible ends (Figure 7C).  
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Figure 7. Modified Baumann/West in vitro end joining. Cell extracts lacking Metnase 
poorly supported the joining of compatible ends with the modified Baumann-West end 
joining assay. A) Inter- and intra-molecular end joining with cell-free extracts. Different 
volumes of reaction mixtures containing 60 µg of whole cell extracts (human 293 cells) 
and 20 ng of 5’-32P-pBS DNA linearized with Kpn I were incubated for 2 hr at 37°C, and 
DNA products were deproteinized and analyzed by 0.8% vertical agarose gel 
electrophoresis. Individual end joining products (circular- monomer, dimer, and trimer) 
were identified by T4 ligase-treated marker DNA. B) Reactions performed in 10 µL total 
volume with 60 µg extract and where indicated, 5 uM of wortmannin, 2 mM ATP, or 100 
uM of dNTPs was included. C) Cell extracts lacking Metnase failed to support joining of 
compatible ends with a gel-based end joining assay. Reaction mixtures (10 µL) were the 
same as Panel A, except the use of two concentrations (30 and 60 µg) of cell extracts. D) 
Relative amount of Metnase expression in 293 cell extracts (lane 1), extracts from cells 
harboring siRNA-control-vector (lane 2), and extracts from Met.siRNA treated cells (lane 
3).  
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1.5. Addition of wt-Metnase to cell extracts lacking Metnase restored DNA end 
joining activity 
Addition of wt-Metnase (0.01 µg) to extracts lacking Metnase significantly increased end 
joining activity (Figure 8A, lanes 6-7 vs. 8-9; Figure 8B, lanes 7 vs. 8-10), whereas it had 
little or no effect on DNA end joining with control cell extracts (Figure 8A, lanes 2-3 vs. 
4-5; Figure 8B, lanes 3 vs. 4-6). This result strongly indicated that a poor end joining 
activity associated with siRNA.Met-treated cell extracts was due to a lack of Metnase. In a 
separate approach, I examined how immunodepletion of Metnase from cell extracts affects 
DNA end joining. Endogenous Metnase was successfully depleted from cell extracts as 
determined by immunoblot analysis (Figure 7D).  
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Figure 8. Metnase addition to depleted extracts, end joining in vitro. Addition of 
wt-Metnase to cell extracts lacking Metnase restored DNA end joining activity. A) 
Increasing amounts (30 and 60 µg) of control extracts (control-siRNA) or extracts lacking 
Metnase (Met-siRNA) were incubated with 20 ng of 5’-32P-pBS DNA linearized with Kpn 
I for 2 hr at 37°C. Where indicated, 0.01 µg of wt-Metnase was included. DNA products 
were analyzed by 0.8% agarose gel electrophoresis. B) HEK293 cell extracts (30 µg) 
(control Ext., Cont-siRNA, and Met-siRNA) were incubated with Kpn I-linearized 
5’-32P-pBS DNA (20 ng) in the presence of increasing amounts of wt-Metnase. End joining 
products (dimer and trimer) were indicated with arrows. 
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Discussion: 
Non-homologous end joining (NHEJ) is the major DNA repair pathway in mammalian 
cells, and involves a rapid, if error-prone, rejoining of the two separated DNA ends (2, 3, 
23, 24). In addition, the pathway functions in processing cell-directed DSBs in V(D)J 
recombination in order to create immunological diversity (99, 105-108). Unlike 
homologous recombination, NHEJ does not require complementary bases at the free DNA 
ends. Earlier cell-free end joining systems identified the Ku70/80 heterodimer, 
DNA-PKcs, XRCC4/Ligase4, and end-processing proteins such as Artemis or the MRN 
complex as required for NHEJ repair in vitro (23, 34, 35, 42-44, 48, 53-57). Given that 
DNA end joining requires processing of non-compatible ends, however, additional 
factor(s) are necessary for completion of NHEJ in a cell-free system. 
  
The Budman and Chu assay is an in vitro intermolecular end joining assay based on PCR 
amplification of joined REF DNA molecules in the presence of cell-free extracts (6, 7). 
While this assay allows for compatible and non-compatible end joining products, it 
explains only one of 10 possible end joining products and may not represent overall end 
joining events occurring in the reactions. The in vitro end joining assay described here is a 
modified version of an intramolecular joining of linear plasmid DNA (102), which couples 
end joining products to E. coli colony formation for quantitative measurement. In addition, 
the colony counts were proportional to the amount of cell extract and linearized DNA used, 
thus experimental results are quantitative. Finally, the assay is Ku70/80 and DNA-PKcs 
dependent, and results in ligation of both compatible and non-compatible ends, key 
features of NHEJ. Therefore, the Budman and Chu systems is a good model of in vivo 
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NHEJ systems. The major modification to the assay is that while Baumann and West 
performed their reactions in a total volume of 20 µL, which tends to favor intermolecular 
dimerization rather than intramolecular re-circularization. To maximize colony formation, 
it was essential to produce as many intact circular plasmids as possible, so the reaction 
volume was increased five-fold to 100 µL, which favored intramolecular end joining.  
Previous work by our lab has shown that Metnase plays a specific but unknown role in 
NHEJ and genomic integration of foreign DNA (13, 20). Metnase-mediated stimulation of 
NHEJ repair in vivo requires both SET and transposase domains, suggesting that Metnase’s 
HLMT activity is also involved in NHEJ (13). I have established that thousands of 
potential Metnase binding sites exist in the genome, and a number of these are in the 
vicinity of nearby genes encoding DNA repair factors. Perhaps Metnase expression or lack 
thereof could result in a modification of expression levels of these proteins. The advantage 
of our modified in vitro end joining assay is the results focus on the role of Metnase itself in 
end joining, and not whether it modifies the expression of additional proteins. Metnase 
knockdown with siRNA has a significant effect on the ability of cell extracts to enable 
linearized pBS’ to dimerize (Figure 8A and 8B). Because the ability of the cell-free system 
to restore dimerization is returned upon introduction of exogenous Metnase, I can conclude 
that Metnase itself has a role in the process other than modulation of expression levels of 
other proteins (Figure 9). Furthermore, since re-introduction of the Metnase D483A 
cleavage mutant did not affect end joining levels, this suggests that Metnase cleavage 
activity plays a major functional role in DNA end joining, perhaps specifically end 
processing.  
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Figure 9. Model of Metnase function in compatible end DNA end-joining. In this 
model, NHEJ begins in the same way as in Figure 1, with Ku70/80 and DNA-PKcs binding. 
Experiments showing re-introduction of purified Metnase into cell extracts lacking the 
protein showed restoration of compatible end DNA end-joining. This may be due to the 
interaction between Metnase and DNA Ligase IV in vivo.   
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AIM 2. INFLUENCE OF METNASE DNA CLEAVAGE ACTIVITY ON JOINING 
OF COMPATIBLE VS. NON-COMPATIBLE ENDS 
 
2.1. Metnase has a preferred singlestranded- and singlestranded-overhang DNA 
cleavage activity    
Although the mechanism by which Metnase enhances NHEJ is still not clear, the 
transposase domain possesses DNA cleavage that may link it to a role in DSB repair. 
Metnase possesses a unique nuclease activity that mediates cleavage of duplex DNA in the 
absence of a TIR sequence (20). Arginine 432 within the HTH motif is critical for 
sequence-specific recognition, but is not required for its DNA cleavage activity. The 
DDE-like motif, on the other hand, is crucial for Metnase DNA cleavage action. A point 
mutation in the DDE motif (D483A) abolished Metnase’s DNA cleavage activity. This 
suggests that Metnase’s DNA cleavage activity, unlike that of other eukaryotic 
transposases, is not coupled to its sequence-specific DNA binding. Since a mutant lacking 
DNA cleavage activity (D483A) failed to support joining of non-compatible ends (Figure 
5), I examined whether Metnase has DNA processing activity. First, I compared ssDNA 
with dsDNA for Metnase’s DNA cleavage activity (Figure 10A). Metnase exhibited a 
significantly higher DNA cleavage activity with ssDNA over dsDNA (Figure 10A, lanes 
2-4 vs. 6-8). A kinetic analysis with partial-duplex DNA further demonstrated that 
Metnase has a DNA cleavage activity preference for ssDNA overhangs (Figure 10B and 
10C). Together, these data support a role for Metnase in DNA end processing. 
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Figure 10. Metnase oligonucleotide cleavage activity. Metnase possesses a 
preferred DNA cleavage activity with ss- and ss-overhang DNA. A) Reaction mixtures 
(20 µL) containing 50 fmol of 5’-32P-labeled 50-mer ssDNA (lanes 1-4) and 50-mer 
dsDNA (lanes 5-8) were incubated with 0 (lanes 1 and 5), 0.05 µg (lanes 2 and 6), 0.1 
µg (lanes 3 and 7), and 0.2 µg (lanes 4 and 8) of wt-Metnase in the presence of 2 mM 
MgCl2. After incubation at 37°C for 120 min, reaction mixtures were analyzed by 18% 
PAGE (8M urea) for DNA cleavage. DNA size makers indicated on the left. B) Kinetic 
analysis of Metnase’s DNA cleavage activity with partial duplex DNA (3’- and 
5’-overhangs). M1 and M2 represent two DNA markers used in this study. C)  DNA 
cleavage sites from Panel B mapped with arrows. 
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2.2. Involvement of Metnase in the processing of non-compatible ends during end 
joining in vitro  
To examine the role for Metnase’s DNA cleavage activity in DNA end joining, I 
further analyzed DNA joining products for non-compatible end processing. Eighteen 
samples from the joining of three separate non-compatible ends [Kpn I-Pst I (3’-3’), 
Bam HI-Hind III (5’-5’), and Bam HI-Pst I (3’-5’) overhangs] were analyzed in the 
presence of cell-free extracts generated from cells expressing different levels of 
Metnase. To assess end processing activity, plasmid DNA isolated from individual 
colonies was amplified by PCR using T7 and M13 reverse primers. PCR products were 
then analyzed by 5% PAGE for end processing. A control DNA without any end 
processing (Figure 11, lane C) produced 210 nucleotides (nts) of PCR product, while 
end joining of non-compatible ends showed up to 85 nts of base-pair loss following 
incubation with cell extracts (Figure 11). A vast majority of end joining products 
showed base-pair loss of up to 10 nts following incubation with cell extracts lacking 
Metnase (Figures 11C and 12), whereas up to 85 nts of base-pair loss was observed in 
DNA end joining reactions performed with cell extracts generated from cells 
over-expressing Metnase (Figure 11B and 12). Cell extracts prepared from control 293 
cells showed DNA end processing activity between the Metnase over-expressor and 
the under-expressor. Together, these results suggest that Metnase’s role in the 
processing of non-compatible ends likely promotes DNA end joining in a cell-free 
extract system.  
 
 
 38 
 
 
 
 
Figure 11. Metnase end processing as measured by PCR. Thirty µg of cell extracts 
containing different levels of Metnase [(293 cells (Ctrl; A), Metnase over-expressor 
(Met+; B), and Metnase-siRNA (siRNA-Met; C)] were incubated for 60 min with 1.0 µg of 
linearized pBS DNA in the presence of 1 mM MgCl2 and 1 mM ATP. Three linearized 
DNA with non-compatible ends [3’-3’ (Kpn I-Pst I), 5’-5’ (Bam HI-Hind III), and 5’-3’ 
(Bam HI-Pst I)] were used for the experiment. End joining products were transformed into 
E. coli and, 18 colonies were picked from each group and analyzed for base-pair loss 
following PCR amplification of isolated plasmid using T7 primer and M13 reverse primer. 
M and C represent 25 bp DNA Step Ladder marker and the control 210 bps of PCR product 
without DNA end processing, respectively. 
A. (Ctrl) (Met+) 
(siRNA-Met) 
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Figure 12. Effect of Metnase on compatible and non-compatible ends. Base-pair loss 
of end joining products in each group was calculated from Figure 9. 
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2.3. A mutant lacking DNA cleavage activity (D483A) failed to support Metnase’s 
function in end joining repair in vivo  
Metnase promotes in vivo end joining activity and mediates genomic integration of foreign 
DNA. A point mutation in the key DDE-like motif (D483A) not only abolishes Metnase’s 
dsDNA cleavage activity (20), but also destroyed its ssDNA cleavage activity (Figure 
13D). To address biological relevance of Metnase’s DNA cleavage activity, I tested 
whether over-expression of the D483A Metnase mutant lacking DNA cleavage activity 
promotes end joining activity in vivo. In vivo end joining was examined by testing the 
ability of Metnase to precisely or imprecisely rejoin a plasmid DNA that was linearized 
within the β-galactosidase gene. Over-expression of wildtype-Metnase (wt-Metnase) 
increased precise and imprecise end joining by 2.3- and 3.2-fold, respectively; cells 
over-expressing D483A had little effect on end joining activity (Figure 13B). It was next 
examined whether the Metnase D483A mutant would stimulate genomic integration of 
exogenous DNA as measured by the assimilation and passage to progeny of a selective 
hygromycin-resistance marker. Stable over-expression of wt-Metnase in HEK293 cells did 
not affect plating efficiency (data not shown). It did however increase integration of a 
plasmid DNA carrying hygromycin by 4-5-fold. Stable over-expression of Metnase 
D483A had no effect on genomic integration (Figure 13C). Together, these data suggest 
that Metnase’s DNA cleavage activity is crucial for its function in end joining and genomic 
integration. 
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Figure 13. Wt-Metnase vs D483A cleavage and colony formation. A) Western blot 
analysis of 293 cells over-expressing wt-Met (WT) or D483A mutant using an 
anti-Metnase antibody (top). Ku80 (bottom) was used as an internal control. B) Effect of 
wt-Met and D483A on intra- molecular end joining of Eco RI-digested pBS. Stable 
expression of either wt-Met or D483A in 293 cells was examined for their imprecise repair 
(white), precise repair (blue), and total NHEJ repair (blue and white colonies). Values are 
averages (±SEM) of 3 distinct determinations. P < 0.01; *P = 0.05. C) Effect of D483A 
mutation on Metnase-mediated promotion of foreign DNA integration. Human 293 cells 
stably transfected with pFLAG2, pFLAG2-wt-Met, or pFLAG2-D483A were transfected 
with increasing concentrations (2 and 4 µg) of pRNA/U6-Hygro, and the number of 
hygromycin- resistant colonies was a measure of genomic integration. D) Reaction 
mixtures (20 µL) containing 50 fmol of 5’-32P-labeled 50-mer ssDNA were incubated with 
0 (lane 1), 0.05 µg (lanes 2 and 5), 0.1 µg (lanes 3 and 6), and 0.2 µg (lanes 4 and 7) of 
wt-Metnase (lanes 2-4) or D483A (lanes 5-7) in the presence of 2 mM MgCl2. After 
incubation at 37°C for 120 min, reaction mixtures were analyzed by 18% PAGE (8M urea) 
for DNA cleavage. DNA size makers indicated on the left. 
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Discussion:  
The Mre11/Rad50/Nbs1 (MRN) complex and Artemis possess 3’-5’ exonuclease and 
endonuclease activity and ssDNA-specific 5’-3’ exonuclease, respectively (46-48). The 
exonuclease activity of the MRN complex functions in processing mismatched DNA ends 
prior to ligation, while its endonuclease serves to open hairpin DNA in V(D)J 
recombination (109). Artemis functions in end-processing and upon phosphorylation by 
DNA-PKcs, functions in V(D)J hairpin opening (110, 111). Like MRN, Werner Syndrome 
protein (WRN) also has 3’5’ exonuclease activity (49-52). The exonuclease activity of 
WRN, a member of the ReqQ-like DNA helicase family, is stimulated by Ku protein, but 
appears to be negatively regulated by DNA-PKcs. Our in vitro work suggests that Metnase 
also belongs to this group of proteins functioning in the non-homologous end joining 
pathway. Extracts from cells overexpressing Metnase protein showed increased base pair 
loss during processing of overhanging DNA ends as compared to extracts containing 
endogenous levels of Metnase. This result suggests a positive function of Metnase 
cleavage activity in end processing (Figure 9 and 10). Furthermore, extracts from cells 
containing diminished amounts of Metnase produced even less base pair loss than extracts 
containing wild-type Metnase. Thus, the more Metnase protein available in the cell extract, 
the more extensively end processing occurs. This result was further supported by data 
showing that extracts from cells overexpressing the Metnase cleavage mutant (D483A) 
Metnase resulted in similar numbers of E. coli colonies (produced from re-ligated 
linearized pBS’ plasmid) as extracts from cells containing only endogenous Metnase. 
Extracts from cells overexpressing Metnase showed a 2-4 fold increase in colony 
formation (Figure 11). DNA end-processing may be necessary for re-ligation even in the 
 43 
presence of compatible ends. Alternatively, DNA end-processing may enhance the existing 
ability of the cell to re-ligate DSBs by increasing a chance for partial annealing between 
two non-compatible ends. 
 
This data suggests a role for Metnase in processing of free DNA ends in NHEJ, a 
reasonable hypothesis regarding end-joining of non-compatible ends. However, it does not 
explain why overexpressed wild-type Metnase enhances re-ligation of compatible ends 
while overexpression of the D483A Metnase does not (Figure 6A and 13). Perhaps a 
currently unrecognized structural alteration exists in the D483A Metnase mutant that 
interferes with its’ association with DNA Ligase IV. Similar to the extracts from cells 
lacking DNA-PKcs or Ku80 (Figure 4C), the extracts prepared from Metnase-siRNA 
treated cells failed to support the joining of compatible ends (Figure 5B). These data 
suggest that Metnase has a separate role in the joining of compatible ends, perhaps by 
interacting with other NHEJ repair factor(s). DNA processing activity also contributes to 
the immunological diversity generated by V(D)J recombination. It remains to be seen 
whether Metnase and its DNA cleavage activity also plays a role in V(D)J recombination.  
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Figure 14. Metnase function in non-compatible DNA end-joining. This data has 
demonstrated that Metnase has a role in both compatible and non-compatible end-joining. 
In this model, Metnase contributes to compatible end joining through association with 
DNA Ligase IV, and to non-compatible end joining through processing of 
non-homologous overhang DNA.  
 
 
 
 
 
 
 
 
 
 45 
AIM 3. HPSO4 IS A METNASE BINDING PARTNER THAT MEDIATES METNASE 
FUNCTION(S) IN NHEJ REPAIR 
 
3.1. Wt-Metnase forms discrete nuclear foci at DSB sites  
I next examined whether Metnase is localized at DNA damage sites following DSB 
damage. Human 293 cells over-expressing FLAG-Metnase were treated with IR (10 Gy), 
and the subcellular localization of FLAG-Metnase was determined at various times. In 
parallel, I stained for Nbs1, a member of the MRE11 complex that is known to berecruited 
to the DSB sites following IR (72, 112). Confocal microscopy showed that distinct nuclear 
foci of Metnase appeared within 2 hrs, peaking at 8 hrs post-irradiation (Figure 15B). 
Importantly, Metnase co-localized with Nbs1, a known DNA repair factor localized at 
DSB sites, following IR (112) (Figure 15A). I also observed a co-localization of Metnase 
with FancD2 (data not shown), another repair factor that was previously shown to 
co-localize with Nbs1 at DSB sites (72).  
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Figure 15. Nuclear localization of Metnase with Nbs1 following DSB. A)  Human 293 
cells over-expressing V5-Met were treated with 0 Gy (top) or 10 Gy (bottom) IR, and 8hrs 
later, cells were fixed and examined for Metnase and Nbs1. Images were obtained 
following double labeling of cells with polyclonal Ab to Nbs1 and monoclonal Ab to 
V5-epitope with Texas Red-conjugated anti-rabbit antibody (A and D) and 
fluorescein-conjugated anti-mouse antibody (B and E). The merged images were shown in 
C and F. B) IR-induced formation of discrete nuclear foci of Metnase. Human 293 cells 
over-expressing V5-Met were treated with of IR (10 Gy), and examined for nuclear 
localization of Metnase at various times.  
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3.2. hPso4 is a Metnase binding partner that redirects Metnase from TIR to non-TIR 
DNA 
To identify Metnase binding partners, I carried out a co-immunoprecipitation experiment. 
Proteomic analysis identified 3 endogenous human proteins in the Metnase 
immunocomplexes (91): the 55-kDa human homolog of the PRP19 gene product of S. 
cerevisiae (PRP19/Pso4) involved in pre-mRNA splicing and DNA repair (22, 98, 113); 
the 50-kDa cleavage product of Metnase; and the 37-kDa human homolog of Spf27, a 
member of the Prp19 core complex also involved in pre-mRNA splicing (98, 113) (Figure 
16). Previous papers had indicated that decreased levels of hPso4 expression negatively 
impacted cell survival following DNA damage (22). In addition, the six WD-40 repeats in 
the hPso4 sequence suggested a potential protein scaffolding role for hPso4 in DNA repair 
complex formation (22). For these reasons, hPso4 was first chosen to examine as a 
potential Metnase binding partner, rather than Spf27.  
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Figure 16. Immunoprecipitation of Metnase binding proteins. Whole cell extracts 
prepared from control 293 cells (lane 1) or cells stably expressing V5-Metnase (lanes 2 and 
3) were incubated with 3 µg of V5-monoclonal antibody at 4°C for 2 hrs, and further 
incubated overnight following addition of 100 µL of Protein G-agarose beads. The 
complex was washed four times with 25 mM Tris-HCl (pH 7.5) containing 250 mM NaCl 
prior to running on a 10% SDS-PAGE and staining with Comassie blue. Lane M represents 
molecular weight markers. Proteins 1, 2, and 3 were identified as Prp19, the gene product 
of S. cerevisiae (PRP19/Pso4), a cleavage product of Metnase (SETMAR), and the human 
homolog of Spf27, respectively. Experiment performed by Dr. Su-Jung Park. 
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To confirm the immunoprecipitation results, the hPso4 cDNA was cloned into a 
pFlag-CMV4 vector (Sigma). The hPso4-containing plasmid was first transfected into 
HEK293 cells using FuGENE6 transfection reagent, then selected for stabile integration by 
propagation in media supplimented with G418 for three weeks. Individual growing 
colonies were selected and amplified to confluence in six-well dishes, and whole cell 
extracts were generated. Cell extracts were run on 10% SDS-PAGE, and Western blot 
analysis with Flag antibody confirmed the presence of the intact hPso4 protein (Figure 
17A). A plasmid encoding V5-Metnase was then transfected into HEK293 cells stably 
expressing Flag-Pso4; Flag-Pso4 was transfected into cells stably expressing V5-Metnase. 
Cultures were allowed to incubate for 48 hours. Cells were lysed in 0.5% NP-40 lysis 
buffer and whole cell extracts were collected. 500 µg of total protein was used to generate 
immunocomplexes with either anti-Flag or anti-V5 antibody. Protein G agarose beads 
were used to collect the immunocomplexes that were then run on 10% SDS-PAGE, 
transferred to nitrocellulose and probed with the indicated antibody (Figure 17B).  
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Figure 17. Physical association between Metnase and hPso4 on western blot. A)  
Western blot analysis of cells transfected with mock, Metnase- or hPso4-expressing vector. 
Ku80 was used as an internal loading control. B) Interaction of Metnase with hPso4. 
Whole cell extracts (100 µg) from 293 cells over-expressing FLAG-Pso4 (lanes 1 and 5), 
V5-Metnase (lanes 2 and 6), or both (lanes 3, 4, 7, and 8) were incubated for 2 hrs with 
either anti-FLAG (lanes 1-4) or -V5 (lanes 5-8) antibody, then for an additional 2 hrs with 
Protein G-agarose. In lanes 3 and 7, human 293 cells over-expressing FLAG-Pso4 were 
transfected with a plasmid expressing V5-Metnase, whereas in lanes 4 and 8, cells 
over-expressing V5-Metnase were transfected with a plasmid expressing FLAG-Pso4. 
After elution, proteins were run on a 10% SDS-PAGE, transferred to membrane, and 
probed with either anti-V5 monoclonal (top panel) or -Pso4 polyclonal (bottom panel) 
antibody.  
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3.3. Metnase associates with non-TIR DNA in the presence of hPso4 
Metnase can bind stably to dsDNA, but only at Terminal Inverted Repeat (TIR) sequences 
(Figure 18A). TIR sequences are unique to transposon proteins, and typically flank a 
movable genomic element on both sides. A transposase binds to the TIR sequence, excises 
the transposon sequence, then moves it elsewhere in the genome. This presumably was the 
original function of the Mariner-like domain of the Metnase fusion protein.  
 
The specific TIR recognized by Metnase consists of a 19-mer core within a 32 base pair 
sequence (83) (Figure 18A). Mutations made to the 19-mer core of the TIR sequence 
decrease the stability of Metnase-DNA binding (Figure 18B and C). Specifically mutating 
two to three nucleotides at a time, I attempted to identify bases essential for Metnase 
association. Ultimately, nearly all of the mutations resulted in a significant reduction in 
Metnase binding affinity, but specific mutations at ten of the nineteen nucleotides were 
sufficient to completely abolish Metnase binding. The 32-mer dsDNA sequence containing 
these 10 mutations was called MAR3M.  
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A.  
  
B.  
   
C.  
 
Figure 18. Metnase binds specifically to TIR dsDNA sequences. A)  5’ TIR sequence 
of an Hsmar1 element. B)  Mutations were designed to the TIR motif to identify the 
sequences necessary for stable Metnase binding. C)  Electromobility shift assay examining 
binding of purified Metnase protein to 5’-radiolabeled TIR dsDNA and its mutants. Protein 
was incubated with labeled DNA in the presence of 50 mM Tris-Cl pH 7.5, 50 mM NaCl, 1 
mM DTT, 0.2 mg/mL BSA, and 5% glycerol for 15 minutes, then analyzed on 5% native 
gel. Slower migrating bands indicate Metnase-TIR complex.  
 
 
Metnase 
Met-TIR  
complex 
Free TIR  
Relative  
Metnase binding DNA sequence of 19-mer of TIR core and mutants 
 
  
     TIR core             5’-GGTGCAAAAGTAATTGCGG-3’    +++++ 
     MARx4        -CCTGCAAAAGTAATTGCGG-      ++  
     MARx6        -GGGTCAAAAGTAATTGCGG-      +++ 
     MARx7        -GGTGACAAAGTAATTGCGG-      +++ 
     MARx8        -GGTGCAACCGTAATTGCGG-      - 
     MARx9        -GGTGCAAAAAGAATTGCGG-      +++ 
     MARx10       -GGTGCAAAAGTCCTTGCGG-      +++++ 
     MARx11       -GGTGCAAAAGTAAGGGCGG-      ++ 
     MARx12       -GGTGCAAAAGTAATTAAAG-      ++ 
     MAR1M       -GGTGACCCCGTAATTGCGG-       - 
     MAR2M       -GGTGCAAAAGTAAGGAAAG-       - 
     MAR3M       -GGTGACCCCGTAAGGAAAG-       - 
 
 
19-mer core 
 
 TIR   -TATTAGGTTGGTGCAAAAGTAATTGCGGTTTT-  
  
MAR3M  -TATTAGGTTGGTGACCCCGTAAGGAAAGTTTT-  
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Previous reports have indicated that hPso4 possesses a sequence-independent binding to 
double-stranded DNA, but not single-stranded DNA (22). The results were not conclusive 
as the authors only tested plasmid DNA and 50-mer oligonucleotide DNA. To test the 
hPso4 protein myself, I purified Flag-Pso4 protein from HEK293 cells stably expressing 
the protein. Cells were lysed in a buffer containing 0.5% NP-40, subjected to dounce 
homogenization 25 times with B pestle, and soluble fractions clarified by high-speed 
centrifugation for one hour at 4°C. The supernate was incubated with anti-Flag antibody, 
loaded onto a protein G agarose column, washed with five column volumes of wash buffer, 
and bound protein was eluted competitively with Flag peptide (500 ng/µL). Eluted 
Flag-Pso4 was dialyzed against 10% glycerol, 0.01% NP-40, and 100 µM DTT and stored 
at -80°C. Radiolabeled single-stranded and double-stranded MAR3M DNA was then used 
to examine Pso4-DNA binding affinity, with results confirming those previously reported 
demonstrating sequence-independent binding to dsDNA, but not ssDNA (Figure 19A).  
 
Given that hPso4 possesses a sequence-independent dsDNA binding activity  and 
physically interacts with Metnase, I examined whether the Metnase-DNA interaction is 
influenced by hPso4. Addition of either protein alone to TIR dsDNA results in a slower 
migrating form of radiolabeled DNA corresponding to TIR bound to protein. When both 
Flag-hPso4 and V5-Metnase were incubated together prior to addition of labeled TIR 
DNA, a third band appeared, which migrated slower than either of the individual 
protein-DNA complexes (data not shown). Addition of either anti-Flag or anti-V5 antibody 
to the gel mobility shift assay reactions indicated the presence of both V5-Metnase and 
Flag-Pso4 in the slower migrating radiolabeled complexes. Furthermore, the presence of 
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supershifted bands following the addition of either V5- or Flag- antibody demonstrated 
that Metnase was able to form a stable complex with hPso4 on both TIR32 and non-TIR 
DNA (MAR3M) (Figure 19B). Previous research has indicated that hPso4 expression is 
induced upon DNA damage, lending support to the hypothesis that hPso4 could redirect 
the Metnase-DNA interaction from TIR to other non-TIR DNA including damaged DNA 
site(s).  
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Figure 19. Stable complex formation on TIR and non-TIR DNA. A) Interaction of 
hPso4 with dsDNA and not ssDNA. Reaction mixtures (20 µL) containing increasing 
amounts of hPso4 and 200 fmol of 5’-32P-labeled ssDNA (top strand of MAR3M) or 
dsDNA (MAR3M duplex DNA) were incubated for 15 min at 25°C and analyzed by 5% 
PAGE. B) Metnase forms a stable complex with hPso4 on both TIR and non-TIR DNA. 
Reaction mixtures (20 µL) containing Metnase (0.2 µg) and/or hPso4 (0.2 µg) were 
incubated with 1 µg of V5- or Flag-antibody for 30 min at 25°C prior to addition of 200 
fmol of 5’-32P-labeled DNA. After 15 min of incubation at 25°C samples were analyzed by 
5% native PAGE. The slowest migrating band observed in the presence of V5-Metnase, 
Flag-hPso4, and dsDNA (TIR32 or MAR3M) was supershifted in the presence of either 
V5- or Flag antibody (lanes 9, 10, 13, and 14), indicating that Metnase and hPso4 form a 
stable complex on dsDNA. The antibody- protein-DNA complexes (supershift) were 
indicated as *. 
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3.4. hPso4 is crucial for localization of Metnase at DSB sites and DNA end joining  
Since Metnase is localized at damage foci following induction of double-strand breaks 
(Figure 15A and 20B), I next examined whether hPso4 is necessary for Metnase to reach 
these DSB sites. Human 293 cells stably expressing Flag-Metnase were transfected with a 
control- or hPso4-siRNA. Forty-eight hours later, cells were treated with IR and examined 
for formation of nuclear foci of Metnase and Nbs1 at DSB sites. Consistent with previous 
data (Figure 15A), cells transfected with a control-siRNA showed distinct Metnase foci 
co-localized with Nbs1 following IR (Figure 20C, second row). Cells transfected with 
hPso4-siRNA showed a somewhat diminished formation of both Nbs1 and Metnase foci. 
However, Metnase did not co-localize with Nbs1 following IR (Figure 20C, fourth row). 
Together, this result suggests that the presence of hPso4 is necessary in order for Metnase 
to form foci at sites of DNA damage. Although the possibility of decreased Metnase 
expression still potentially exists, low basal levels of hPso4 do not affect Metnase 
expression, so the possibility of an effect following DNA damage seems unlikely. I 
hypothesize that the diminished foci response is due to the inability of Metnase to associate 
with non-TIR DNA in the absence of hPso4.  
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Figure 20. Metnase does not form foci in vivo in the absence of hPso4. A) Western 
analysis of IR-induced expression of hPso4. PCNA was used as a loading control. B) 
Co-localization of Metnase with hPso4 following DSB damage in vivo. Human 293 cells 
over-expressing Flag-Metnase were treated with 0 Gy (top panels) or 10 Gy (bottom 
panels) of IR. Following 8 hrs of incubation, cells were fixed and examined for cellular 
localization of Metnase and/or hPso4 using anti-Flag monoclonal (Sigma) and -hPso4 
polyclonal (Merck, Darmstadt, Germany). Images were obtained following double 
labeling of fixed cells with polyclonal antibody to hPso4 and monoclonal antibody to 
Flag-epitope with Texas Red-conjugated anti-rabbit antibody andfluorescein-conjugated 
anti-mouse antibody. A co-localization of Metnase and hPso4 was examined using a 
Zeiss LSM-510 confocal microscopy. C) Effect of hPso4 on formation of discrete nuclear 
foci of Metnase at DSB sites. Human 293 cells stably expressing Flag-Metnase were 
treated with a control- or hPso4-siRNA for 48 hrs. Following 0 or 10 Gy of IR treatment, 
cells were examined for formation of nuclear foci of Metnase and Nbs1 at DSB sites. 
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To further understand the Metnase-hPso4 interaction with DNA, I examined the ability of a 
Metnase mutant lacking the SET domain (Met:dSET) for interaction with hPso4 on DNA. 
Met:dSET retained its TIR-binding activity, however it failed to form a complex with 
hPso4 on TIR or non-TIR DNA (Figure 21). These data suggest that the transposase 
domain essential for Metnase-TIR interaction is not sufficient for the Metnase-hPso4 
interaction with either TIR or non-TIR DNA. The SET domain may be directly responsible 
for interaction with hPso4, although I was not able to test a mutant lacking transposase 
domain because it was unstable and quickly degraded (data not shown). Whether this 
degradation occurred in vivo or following cell lysis is unknown. If it were the latter, a larger 
quantity of cells could be grown and harvested in the cold room to potentially recover some 
measurable amount of protein.  
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Figure 21. Transposase domain is not sufficient for Metnase-hPso4 binding. 
Wt-Metnase or a mutant lacking the SET domain (Met:dSET) was incubated with 32P-TIR 
(lanes 1-6) or non-TIR (32P-MAR3M, lanes 7-12) in the absence or the presence of hPso4. 
Following a 15 min incubation, protein-DNA complexes were analyzed by 5% 
non-denaturing PAGE. Individual protein-DNA complexes were marked on the left side of 
the figure.  
 
 
 
 
 
 
 
 
 
 
 
 60 
3.5. hPso4 is necessary for DNA end joining in vivo and in vitro 
Pso4 is a dsDNA binding protein that plays a major but undefined role in mammalian DNA 
repair (22). My confocal microscopy study suggests that one of the roles of hPso4 in DSB 
repair is to introduce Metnase to DSB sites through a physical interaction (Figure 20B, C). 
This result prompted us to test whether hPso4 influences Metnase’s function in DSB repair 
in vivo. Human 293 cells (1.0 x 105 per plate) were transfected with Metnase-siRNA, 
hPso4-siRNA, or a control-siRNA, and I examined how targeted inhibition of how hPso4 
expression would affect Metnase-mediated stimulation of in vivo end joining. Treatment of 
cells with hPso4-siRNA not only inhibited colony formation in mock cells, but also 
abolished Metnase-mediated stimulation of DNA end joining coupled to genomic 
integration (Figure 22B). Furthermore, extracts prepared from cells transfected with 
hPso4-siRNA, similar to those treated with Metnase-siRNA, failed to support DNA end 
joining in vitro (Figure 22C), suggesting that hPso4 has an indispensible role in DBS 
repair. 
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Figure 22. Lack of hPso4 negatively effects inter/intra-molecular end joining. A) 
HEK293 cells stably expressing either Flag-Metnase or Flag-hPso4 were transfected with 
siRNA for Metnase or hPso4, or scrambled control siRNA. Cell extracts were collected 
and analyzed by western blot using anti-Flag antibody. PCNA expression was used as a 
siRNA control. B) Mock HEK293 and Metnase over-expressor cells were treated with 
scrambled siRNA, Metnase siRNA, or hPso4 siRNA, and cell extracts were collected and 
used in a modified end-joining assay as described in Figure 2. C)  Inter- and 
intra-molecular end joining with cell-free extracts. Different volumes of reaction mixtures 
contained 60 µg of whole cell extracts (human 293 cells) and 20 ng of 5’-32P-pBS DNA 
linearized with KpnI. Extracts consisted of either HEK293 (Cont. exts), 
Metnase-overexpressor (Met+), Metnase-underexpressor (Met-siRNA), 
hPso4-overexpressor (hPso4+), or hPso4-underexpressor (hPso4-siRNA). Reactions were 
incubated for 2 hr at 37°C, and DNA products were deproteinized and analyzed by 0.8% 
vertical agarose gel electrophoresis. Individual end joining products (circular- monomer, 
dimer, and trimer) were identified by T4 ligase-treated marker DNA.  
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Discussion:  
Metnase is a SET and transposase fusion protein with histone lysine methyl transferase, 
sequence (TIR)-specific DNA binding, assembly of paired-end complex (PEC) and DNA 
cleavage activities (13). My in vitro and in vivo end joining studies have suggested that 
Metnase is involved in NHEJ. It remains uncertain how a protein that can only bind to 
DNA at specific sequences might function in genomic repair. In these experiments, I show 
that a second DNA repair factor, hPso4, is a binding partner for Metnase that allows it to 
associate with necessary non-TIR sequences. hPso4 is a human homolog of the 
PS04/PRP19 gene in S. cerevisiae that has pleiotropic functions in DNA recombination 
and error-prone repair (22, 98, 113). hPso4 is induced by DNA damage, including IR and 
cisplatin (22), but also appears to exist at minimal levels intracellularly in the absence of 
DNA damage, for example as a nuclear matrix component (22, 95). Metnase and hPso4 
function as DNA repair factors, both show enhanced chromatin association following 
DNA damage, and this along with our observation of a direct physical interaction (Figure 
19B) suggest they might function together at sites of DSBs. Although hPso4 is a direct 
binding partner of Metnase, in our immunocomplexing assays of Metnase, the human 
homolog of Spf27, a member of the Prp19 core complex involved in pre-mRNA splicing 
(98, 113), was detected. hPso4 is also a member of the pre-mRNA splicing complex along 
with Cdc5L and Plrg1. It is currently unknown whether Metnase functions in this complex, 
or whether Spf27 was indirectly associated. The pre-mRNA splicing complex has been 
linked to V(D)J recombination through an association between hPso4 and terminal 
deoxytransferase (TdT) (22), which adds nucleotides to DNA ends (114-116). In addition, 
the pre-mRNA splicing complex has been linked to NHEJ through an association between 
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Cdc5L and WRN, a 3’5’ exonuclease involved in DNA end processing (98). It is 
possible that the Metnase-hPso4 interaction is a part of a much larger complex that 
participates in DSB repair in vivo. One way to indirectly test this would be to clone another 
member of the pre-mRNA splicing complex into a tagged vector system and look for 
overlap in foci between it and Metnase following DNA damage. If this result were positive, 
knockdown assays of other members of the splicing complex would suggest whether the 
complex functioned alongside or in concert with Metnase.  
 
Metnase recognizes the 19-mer core of the 5’-terminal inverted repeats (TIR) of the 
Hsmar1 element (Figure 18). Approximately half of the human genome derives from 
transposable elements, and there are over 7,000 potential Metnase binding sites in the 
human genome. The recruitment of the Metnase to the TIR sites may form a gene 
regulatory network that affects global gene expression in the absence of DNA damage 
(117). Once genomic damage is recognized, however, expression of hPso4 is upregulated 
(Figure 19A) and forms a stable complex with Metnase. Unlike Metnase, hPso4 has 
sequence-independent dsDNA binding activity, permitting Metnase to reach both TIR and 
non-TIR DNA equally (Figure 19B). Following IR treatment, Metnase formed discrete 
nuclear foci and co-localized with the MRN complex (Mre11-Rad50-Nbs1) (Figure 20C). 
Since one known function of the MRN complex is to recognize DNA damage and localize 
to those sites (72, 112), it is reasonable to conclude that the Metnase foci are occuring at 
sites of DSB damage. This could be confirmed using targeted DNA damage in vivo, then 
looking for Metnase accumulation at these sites under confocal microscope. 
Downregulation of hPso4 using siRNA prevented the localization of Metnase and Nbs1 to 
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damage sites (Figure 20C), suggesting that hPso4 interaction is essential for migration of 
Metnase to DSBs. Furthermore, the transposase domain of Metnase is not sufficient to 
allow the interaction with hPso4. A deletion mutant removing the SET domain from 
Metnase failed to interact with hPso4 on gel shift assay (Figure 21). It is currently unknown 
whether the SET domain alone is responsible for hPso4 interaction, or whether its presence 
is merely necessary for the two proteins to bind. The SET domain of Metnase is the domain 
responsible for TIR-specific DNA binding. Metnase cleavage activity comes from the 
transposase domain, so it remains to be seen whether the SET domain contributes to 
Metnase’s function in DSB repair via histone lysine methyl transferase activity, interaction 
with hPso4, or both.  
 
In these experiments, I showed that physical association of hPso4 with Metnase allows 
Metnase to localize to non-TIR regions in the genome, such as sites of DNA damage. 
Currently unanswered are questions regarding hPso4’s influence on Metnase HLMT 
activity. Although hPso4 is upregulated following DNA damage, it exists at very low basal 
levels in the cell in the absence of damage, functioning as part of the nuclear matrix and in 
the pre-mRNA splicing complex. Our current work suggests that very little free hPso4 
exists outside of these two components, but the physical interaction between the two 
proteins precludes dismissal of additional functional interactions between Metnase and 
hPso4. Pso4/Prp19 is a U-box protein with associated E3 ubiquitin ligase activity that is 
critical for its function in pre-mRNA splicing in vivo (113, 118-121). Given that 
ubiquitylation is rapidly induced at repair foci in response to DNA damage and can be 
detected using an antibody that specifically detects conjugated ubiquitin, hPso4’s E3 ligase 
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activity may also play a role in DSB repair. It remains to be seen whether Metnase is a 
physiological substrate of hPso4.  
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AIM 4. IN VITRO ANALYSIS OF METNASE AND/OR HPSO4 BINDING TO 
DSDNA 
 
4.1. Metnase exists as a dimer that mediates a synaptic complex with two TIRs in 
opposite orientation  
The TIR-specific DNA binding activity of Metnase promotes a paired-end complex (PEC) 
of two TIR DNAs, suggesting that it functions as a dimer (18). To address the 
stochiometric status of Metnase molecule(s), I examined whether Metnase molecules 
interact with each other in vivo. Using FuGENE6, a plasmid FLAG- or V5-Metnase was 
transfected using FuGENE6 into HEK293 cells stably expressing V5- or FLAG-Metnase, 
respectively. Cells were allowed to grow for 48 hours, then cells were lysed and extracts 
examined for interaction between Metnase molecules. FLAG- and V5-Metnase were 
co-immunoprecipitated by a reciprocal pull-down of Metnase using either anti-V5 or 
-FLAG antibody followed by probing with the reciprocal antibody upon western analysis 
(Figure 23). Results suggest that Metnase exists as more than one molecule in vivo.  
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Figure 23. Physical interaction between Metnase molecules in vivo. Human 293 cells 
stably expressing V5-Metnase were transfected with a vector harboring Flag-Metnase, and 
293 cells stably expressing Flag-Metnase were transfected with a vector expressing 
V5-Metnase. Forty-eight hours later, cell extracts were prepared and incubated with either 
an anti-V5 (panel A) or -Flag (panel B) monoclonal antibody for co-immunoprecipitation 
of V5- and Flag-Metnase. Following immunoprecipitation, samples were run on 10% 
SDS-PAGE and immunoblotted using either anti-Flag or -V5 antibody as indicated on the 
left side of the figure. In lanes 1-6, either purified Flag- or V5-Metnase (lanes 1 and 2) or 
whole cell extracts (WCE, lanes 3-6) were included as a loading control. 
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To determine whether Metnase actually exists as a dimer, I examined the native molecular 
mass of Metnase by glycerol gradient centrifugation. For this, purified Flag-Metnase was 
mixed with protein markers [urease (260 kDa, 11.8S), alcohol dehydrogenase (A.D., 
150 kDa, 7.4S), bovine serum albumin (BSA, 67 kDa, 4.4S), and carbonic anhydrase 
(C.A., 29 kDa, 2.8S)] and sedimented on a 10-35% glycerol gradient by centrifugation at 
45,500 rpm/4°C/26 hours. The migration of the 78 kDa Metnase was identified both by 
probing with anti-Flag on western blot, and by using its affinity for TIR DNA binding. 
After testing each of the gradient fractions, I determined that Metnase was eluted at the 
position of Alcohol dehydrogenase (150 kDa) (Figure 24). Taken together, the data 
indicate that Metnase indeed exists as a dimer.  
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Figure 24. Glycerol gradient analysis of Metnase. Metnase and its TIR binding activity 
eluted at a dimer position on a glycrol gradient centrifugation. A) SDS-PAGE of 
immunoaffinity purified Flag-Metnase (lane 1) and Flag-hPso4 (lane 2) used in this study. 
Lane M represents protein markers. B) Glycerol gradient sedimentation of wt-Metnase. An 
aliquot of the immunoaffinity-purified wt-Metnase was diluted with an equal volume of 
buffer B (50 mM Tris-HCl, pH 7.5, 5 mM DTT, 200 mM NaCl, 0.02% (w/v) NP40, and 0.5 
mM EDTA, pH 8.0) containing protein markers [urease (260 kDa, 11.8S), alcohol 
dehydrogenase (A.D.; 150 kDa, 7.4S), bovine serum albumin (BSA; 67 kDa, 4.4S), and 
carbonic anhydrase (C.A.; 29 kDa, 2.8S)] and layered onto a 4.2-mL linear 10-35% 
(vol/vol) glycerol gradient. Gradients were centrifuged at 45,500 rpm for 26 hr in a 
Beckman SW55 rotor at 4°C. Fractions were collected from the bottom and analyzed for 
wt-Metnase (western blot, top panel) and TIR-specific DNA binding activity (bottom 
panel). Arrows marked indicate positions of protein markers. L.O. = load-on; protein 
before it was loaded onto the gradient.  
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The Metnase dimer supported a paired-end complex (PEC) with TIR DNA in vitro. Thus, I 
examined whether the Metnase dimer mediates formation of a synaptic complex with 
dsDNA containing two TIRs at the ends. For this, wt-Metnase was incubated with a 
double-stranded 118-mer oligonucleotide containing two 19-mer of TIR core at both ends, 
either with both TIRs running in a forward sequence (5’  3’) (FF-118), or with one TIR 
facing forward and the other running in reverse (3’  5’) (FR-118) (Figure 25A). Two 
distinct complexes were formed when Metnase was incubated with FF-118 containing two 
TIRs with same orientation. An incubation of Metnase with FR-118 containing two TIRs 
with opposite orientation produced only one complex (Figure 25B). Transposase 
sequence-specific DNA binding occurs in an orientation-dependent manner,  Therefore, 
the result suggests that Metnase dimer induces DNA looping via a synaptic complex with 
DNA containing two TIRs in opposite orientation. Additional experiments could be 
performed to clarify this result. For instance, treatment with a restriction endonuclease in 
the region of sequence between the two TIR sequences might confirm the distinction 
between a looping structure and a 118-mer with only a single Metnase dimer attached. By 
labeling both the 5’ and 3’ ends of the 118-mer, if the looping model is correct, 
endonuclease restriction would result in a single radiolabeled species on an agarose gel. If, 
however, the model of a Metnase dimer sitting on only one TIR sequence is correct, then 
restriction would show two radiolabeled species – one quickly migrating, and one 
migrating much slower.  
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Figure 25. Metnase dimer interaction with dsDNA containing multiple TIRs. A) Two 
DNA substrates used in this study. FF-118 and FR-118 contain two 19-mer of TIR core 
with different orientations (indicated with arrows). B) Interaction of wt-Metnase with 200 
fmol of either 32P-labeled FF-118 (lanes 1-5) or 32P-FR-118 (lanes 6-10) was examined 
using vertical 0.8% agarose gel electrophoresis. One or two molecules of Metnase dimer 
bound to the FF-118 were indicated on the left, while one Metnase dimer forming a 
synaptic complex with FR-118 was indicated on the right side.  
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4.2. Metnase forms a 1:1 stoichiometric complex with hPso4 on dsDNA   
Metnase forms a stable interaction with hPso4 on DNA, and hPso4 is necessary for Metnase 
foci localization and repair function in vivo. Thus, I next investigated the physical 
characteristics of the Metnase-hPso4 interaction in vitro. Metnase showed TIR-specific DNA 
binding only (Figure 18C), while hPso4 interacted with dsDNA in a non-sequence-specific 
manner (Figure 19A). I further demonstrated the interaction between the Metnase-hPso4 
complex with dsDNA. I carried out a stoichiometric analysis of Metnase and hPso4 binding to 
both TIR and non-TIR (MAR3M) DNA using gel mobility shift assays. Increasing amounts of 
hPso4 tetramer were added to a fixed amount of Flag-Metnase. The Metnase-hPso4-TIR 
complex formed in direct proportion to the increased amounts of hPso4-tetramer (121) (0.25 to 
2.0 pmol) in the presence of fixed amounts of Metnase (either 0.9 or 1.8 pmol) (Figure 26). 
Bands detected on the radioblots were excised and 32P levels were measured by scintillation 
count to determine femtamoles of 32-mer present in each band. Plotting of protein-DNA 
complex versus hPso4 concentration showed a direct negative relationship between 
Metnase-TIR complex formation and hPso4 concentration. At the same time, 
Metnase-Pso4-TIR complex formation increased in an inverse manner. A similar result was 
obtained when non-TIR DNA (MAR3M) was used instead of TIR (Figure 27). Taken together, 
the data suggest that the Metnase dimer forms a 1:1 stoichiometric complex with 
hPso4-tetramer on dsDNA.  
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Figure 26. Metnase has 1:1 stochiometry with hPso4 on TIR. Reaction mixtures (20 
µL) containing fixed amount of Metnase (0 or 0.9 pmol) were incubated with increasing 
amounts of hPso4 (0.25, 0.5, 1.0, and 2.0 pmol) for 15 min prior to addition of 400 fmol of 
5’-32P-labeled DNA. Following 15 min incubation at 25°C, the protein-DNA complexes 
were analyzed by 5% native PAGE in the presence of 1X TBE. For quantification, 
individual bands were excised from dried gel and measured for radioactivity. In the lower 
panel, the amount of the Metnase-TIR and Metnase-hPso4-TIR complexes (fmol) were 
calculated.  
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Figure 27. Titration of Metnase and hPso4 on non-TIR DNA. Reaction mixtures (20 
µL) were the same as those described in Figure 22, except for the use of 5’-32P-labeled 
non-TIR DNA (MAR3M, 400 fmol) instead of TIR. Individual protein-DNA complexes 
were marked on the left side. For quantification, individual bands were excised from dried 
gel and measured for radioactivity.  
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4.3. hPso4, once forming a complex with Metnase, is solely responsible for binding to 
dsDNA 
Metnase possesses TIR-specific DNA binding activity, whereas hPso4 binds to dsDNA 
with no sequence preference (22). Given that both Metnase and hPso4 bind to TIR DNA 
(Figure 19B), each protein in the Metnase-hPso4 complex may independently interact with 
TIR. Alternatively, only one protein in the Metnase-hPso4-TIR complex is responsible for 
DNA binding. To examine this, I carried out a stoichiometric analysis where Metnase, 
hPso4, and the Metnase-hPso4 complex were quantitatively analyzed for binding to TIR. 
Increasing stochiometric amounts of both Metnase and hPso4 were added to 400 fmol 
32P-labeled TIR. The amount of TIR bound to each protein (Metnase or hPso4) was almost 
identical to those interacting with the Metnase-hPso4 two-protein complex (Figure 28). 
This experiment involves an excess of labeled DNA with protein as the limiting factor. If it 
were possible for both Metnase and hPso4 to associate with each other and still each bind 
DNA, the total femtomoles of 32P-labeled TIR in the two-protein complex would have 
approached a two-fold increase over that measured in either single-protein DNA complex. 
However, the scintillation count of labeled DNA was nearly identical. This suggests that 
either Metnase or hPso4 sacrifices its ability to bind to DNA when it associates with its 
binding partner. The amount of TIR DNA bound to Metnase or hPso4 was also almost 
identical to those bound to the Metnase-hPso4 two-protein complex when increasing 
amounts of TIR were added to the reaction mixtures in the presence of fixed amounts of 
protein (Figure 29). Together, these results suggest that either Metnase or hPso4, but not 
both, is responsible for interacting with TIR DNA in formation of the Metnase-hPso4-TIR 
complex.  
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Figure 28. Stochiometric analysis of Metnase and/or hPso4 bound to TIR DNA. 
Stoichiometric analyses of binding of Metnase, hPso4, and the Metnase-hPso4 to TIR 
DNA. Reaction mixtures (20 µL) containing indicated amounts of Metnase (lanes 2-5), 
hPso4 (lanes 6-9), or 1:1 mixture of Metnase-hPso4 (lanes 10-13) were incubated for 15 
min at room temperature prior to addition of 400 fmol of 32P-TIR DNA. After 15 min 
incubation, the protein-DNA complexes were analyzed by 5% native PAGE. Individual 
protein-DNA complexes (marked on the left side) were quantified following excision of 
individual bands from dried gel for measurement of radioactivity. In the lower panel, the 
Metnase-TIR, hPso4-TIR, and Metnase-hPso4-TIR complexes (fmol) were quantified. 
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Figure 29. Relative binding activity of Metnase and hPso4, alone or together. Two 
pmol of Metnase, hPso4, or Metnase-hPso4 complex were pre-incubated at 25°C for 15 
min before further incubation in the presence of increasing amounts (0.05, 0.1, 0.2, and 0.4 
pmol) of 32P-TIR DNA. Following incubation, the reaction mixtures were analyzed by 5% 
native PAGE. Individual protein-DNA complexes (marked on the left side of the figure) 
were quantified using the NIH image program (version 1.62). 
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I then examined which protein in the Metnase-hPso4-DNA complex is responsible for 
binding to DNA. For this, I compared the Metnase-hPso4 complex with hPso4 for 
quantitative binding to non-TIR DNA (MAR3M). The amount of MAR3M bound to hPso4 
was almost identical to those bound to the Metnase-hPso4 complex (Figure 30A), 
suggesting that hPso4 in the Metnase-hPso4 complex is equally effective as free hPso4 in 
interaction with non-TIR DNA. Next, I carried out a competition experiment where the 
interaction of Metnase and/or hPso4 with 32P-TIR DNA was examined in the presence of 
non-labeled competitor DNA. The Metnase-32P-TIR complex was significantly inhibited 
only in the presence of non-labeled TIR (Figure 30B, lanes 2-6), whereas formation of the 
the hPso4-32P-TIR complex was competitively inhibited in the presence of both TIR and 
non-TIR DNA (Figure 30B, lanes 7-11). Similar to the hPso4-TIR, the 
Metnase-hPso4-32P-TIR two-protein complex was inhibited by both TIR and non-TIR 
DNA (Figure 30B, lanes 12-16), suggesting that hPso4 is solely responsible for binding to 
either TIR or non-TIR DNA in the Metnase-hPso4-DNA complex.  
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Figure 30. Protein interaction negatively influences Metnase-TIR binding. A) 
Stoichiometric analysis of Metnase, hPso4, and the Metnase-hPso4 complex bound to non-TIR 
(MAR3M) DNA. Reaction mixtures (20 µL) were the same as those indicated in Figure 24, 
except for the use of nonTIR DNA (MAR3M). Individual protein-DNA complexes (marked on 
the left side) were quantified following excision of individual bands from dried gel for 
measurement of radioactivity. B) The Metnase-hPso4-TIR complex is competitively inhibited 
by both TIR and non-TIR DNA. Metnase, hPso4, or the Metnase-hPso4 complex (2 pmol) was 
pre-incubated for 15 min at room temperature followed by an addition of 32P-TIR DNA (200 
fmol) in the presence of 2- or 5-fold excess of unlabeled TIR or non-TIR (MAR3M) DNA. 
Following 15 min incubation, the reaction mixtures were analyzed by 5% native PAGE. 
Individual protein-DNA complexes were marked on the left side. 
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4.4. hPso4 preferentially interacts with free Metnase over Metnase bound to TIR 
The stoichiometric analyses shown in Figures 28-30 raised a question as to how hPso4 and 
not Metnase is responsible for dsDNA binding when the two proteins form a stable 
complex. One possibility is that hPso4, when in a complex with Metnase, prevents 
Metnase from binding to DNA. If so, Metnase already bound to DNA (TIR) may not be as 
effective as free Metnase in its ability to interact with hPso4. To test this possibility, I 
carried out an order of addition experiment. Metnase (or hPso4) was pre-incubated with 
DNA (TIR or non-TIR DNA) before or after addition of a stoichiometric amount of hPso4 
(or Metnase), and was analyzed for formation of the Metnase-hPso4-DNA complex. When 
Metnase was pre-incubated with hPso4 or hPso4-DNA mixtures, most, if not all, of the 
Metnase protein was able to form a stable complex with hPso4 on dsDNA (TIR or 
non-TIR) (Figure 31, lanes 4, 6, 10, and 12). On the other hand, formation of the 
Metnase-hPso4-DNA complex was somewhat reduced when Metnase was pre-incubated 
with DNA before addition of hPso4 (Figure 31, lanes 5 and 11), suggesting that hPso4 
preferentially interacts with free Metnase over Metnase bound to TIR.  
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Figure 31. Metnase and hPso4 order of addition reaction. hPso4 preferentially 
interacts with free Metnase over Metnase bound to DNA. Two pmol of Metnase (lanes 2 
and 8), hPso4 (lanes 3 and 9), or both (lanes 4-6 and 10-12) were incubated with 200 fmol 
of either TIR or nonTIR (MAR3M) DNA for formation of the protein(s)-DNA complexes. 
When both Metnase and hPso4 were present, the components were assembled in 3 separate 
ways: A (lanes 4 and 10), Metnase and hPso4 were preincubated for 15 min prior to 
addition of DNA; B (lanes 5 and 11), Metnase was preincubated with DNA first before 
addition of hPso4; C (lanes 6 and 12), hPso4 was incubation with DNA first, before 
addition of Metnase. Following 15 min incubation, the reaction mixtures were analyzed by 
5% native PAGE. Individual protein-DNA complexes were marked on the left side. 
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To further understand this, I tested whether Metnase undergoes a conformational change 
upon binding to DNA. For this, wt-Metnase was examined for tryptic digestion patterns in 
the presence and absence of dsDNA. In the absence of DNA, wt-Metnase was cleaved into 
one major tryptic product (~40 kDa), however the 40 kDa cleavage product was further 
cleaved into smaller fragments (25 kDa and 15 kDa) in the presence of either TIR or 
non-TIR DNA (Figure 32). This result suggests that upon interaction with DNA, wild-type 
Metnase undergoes a conformational change that is not in favor of the Metnase-hPso4 
interaction.  
 
 
 
Figure 32. Trypsin digestion of Metnase in presence of TIR and non-TIR DNA. 
Reaction mixtures (60 µL) contained 0.1 M Tris-HCl (pH 8.5), and 100 ng/µL of 
wt-Flag-Metnase. Where indicated, 50 ng/µL of either TIR (lanes 4-6) or MAR3M (lanes 
7-9) was added. After incubation at room temperature for 15 min, 50 ng of trypsin was 
added to the reaction. Reaction mixtures were then incubated at 37°C and aliquots were 
removed from the reactions at the indicated time points. Samples were mixed with gel 
loading buffer, boiled for 5 min, and loaded onto a 12% SDS-PAGE. The gel was then 
subjected to a Western blot analysis using an anti-FLAG monoclonal antibody. 
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Discussion: 
This stoichiometric analysis has several interesting implications for the architecture of the 
Metnase-hPso4 complex on dsDNA. First, Metnase dimer forms a 1:1 stoichiometric 
complex with hPso4-tetramer on dsDNA (Figure 26). Although hPso4 is a direct binding 
partner of Metnase, Metnase also pulled down the human homolog of Spf27, a member of 
the Prp19 core complex involved in pre-mRNA splicing. Given that Pso4 is part of the 
pre-mRNA splicing complex consisting of Pso4, Cdc5L, Plrg1, and Spf27, the 
Metnase-hPso4 complex may be a part of the bigger complex including other members of 
the pre-mRNA splicing complex in vivo. Secondly, although both Metnase and hPso4 
independently interact with TIR DNA, hPso4 is solely responsible for binding to dsDNA 
once the two proteins form a stable complex. This claim is based on the findings that i) the 
Metnase-hPso4 complex interacted with same stoichiometric amount of non-TIR DNA as 
the TIR DNA (Figure 26 and 27), ii) the Metnase-hPso4 complex interacted with same 
number of TIR molecules as Metnase or hPso4 alone did (Figure 28), and iii) formation of 
the Metnase-32P-TIR complex was significantly inhibited by excess of TIR and not by 
non-TIR, whereas the Metnase-hPso4-TIR complexes were equally inhibited by both TIR 
and non-TIR DNA (Figure 30B).  
 
It is not clear how Metnase’s TIR binding activity is not functioning when it forms a 
complex with hPso4, although both Metnase and hPso4 possess very similar binding 
affinity to TIR DNA. It is possible that hPso4, once forming a complex with Metnase, may 
directly interfere with Metnase’s DNA binding domain (helix-turn-helix motif). This 
notion is supported by a finding that Metnase bound to TIR DNA was less effective than 
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free Metnase in interacting with hPso4 (Figure 31). Further structural study would be 
necessary to clarify this intriguing issue. Considering that hPso4 is induced following IR 
treatment in vivo (22), formation of a stable Metnase-hPso4 complex likely occurs in 
response to DNA damage. Pso4 also undergoes structural alterations in response to DNA 
damage. The Metnase-hPso4 complex, once formed, likely goes to non-TIR sites such as 
sites of DNA double-strand breaks, since hPso4 is solely responsible for binding to DNA in 
forming the Metnase-hPso4-DNA complex. It would be interesting to see whether hPso4 
also affects Metnase’s other biochemical functions such as DNA cleavage activity and 
histone lysine methyl transferase activity.  
 
Two separate roles for Metnase in NHEJ repair 
Although the specific role Metnase plays in NHEJ repair is still not clear, a deletion of 
either the SET or the transposase domain abrogated its function in DNA repair, indicating 
that both domains are required for this function. Given that over-expression of Metnase 
promotes joining of both compatible- and non-compatible ends, I propose that Metnase has 
at least two separate functions in NHEJ repair (Figure 33). In the joining of compatible 
ends (I), Metnase-Lig4 interaction is induced following DNA damage, which promotes 
recruitment of the XRCC4-Lig4 complex, an essential player in the ligation step. Since 
wt-Metnase and not the D483A lacking DNA cleavage activity restores DNA end joining 
in vivo and in vitro, Metnase likely functions to promote the processing of non-compatible 
ends, a prerequisite step for the joining of non-compatible ends (II). 
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Figure 33. Proposed model of hPso4-Metnase function. Ionizing radiation causes 
double-strand breaks in cells, and also induces production of hPso4 by the cell. Increased 
levels of hPso4 favor binding to free Metnase, and the protein complex co-migrates to sites 
of damage. If the damaged ends are compatible (I), end-processing may not be necessary, 
and association with the DNA Ligase IV / XRCC4 complex and Cernunnos-XLF may be 
all that is required for re-ligation of the damaged strands. If the damaged ends are not 
compatible (II), processing of the ends is necessary before re-ligation can occur. Ku70/80 
and the DNA-PK catalytic subunit are required, as well as Artemis, WRN protein, and the 
Mre11-Rad50-Nbs1 complex.  
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FUTURE DIRECTIONS: 
 
While this work can serve as a basis for study of the functional and biochemical 
implications of the interaction between Metnase and hPso4, much work remains to be done. 
Currently the crystal structure analysis of Metnase is nearly complete, but the 
three-dimensional structure of the Pso4 tetramer remains a mystery. It would be interesting 
to determine the crystal structure of hPso4 to help identify the residues essential for 
interaction with Metnase. Similarly, this could lend insight into whatever conformational 
change is occurring in Metnase upon binding to TIR DNA, and why this change negatively 
influences the ability of hPso4 to bind.  
 
The recent identification of phenylalanine 460 as the residue essential for Metnase 
dimerization has also suggested a number of new paths to follow. Purification of a mutant 
protein lacking the ability to dimerize will allow us to more closely examine the role of 
Metnase in global gene regulation by looking at up- and down-regulation of protein 
expression using a microarray system. The exact mechanism of DNA looping will also be 
settled. A Metnase mutant lacking the ability to dimerize will by necessity also lack the 
looping activity hypothesized in this work. In addition, a dimerization mutant will provide 
further insight into the role of Metnase in NHEJ. Addback of wild-type versus dimerization 
mutant Metnase to an in vitro end joining reaction will show whether Metnase must exist as 
a dimer in order to functionally assist in NHEJ. Specifically, does monomeric Metnase 
retain its cleavage activity?  What implications does Metnase existing as a monomer versus 
a dimer have on cleavage of specific single-stranded DNA overhangs?  It would also be 
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interesting to see how hPso4 is able to interact with Metnase, if at all. While monomeric 
Metnase may not be able to bind DNA by itself, perhaps Metnase could still reach sites of 
DNA damage through its interaction with Pso4.  
 
Clearly Metnase and hPso4 both have roles in DNA repair that have not fully been realized. 
Hopefully these issues can be explored more thoroughly in the future.  
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